INTERNATIONAL CONFERENCE ON CANCER NURSING...Nursing and Hong Kong Oncology Nursing Group, it is a...

September 4-7, 2016 • HONG KONG, CHINA • Sheraton Hong Kong Hotel & Towers

ICCN 2016INTERNATIONAL CONFERENCE

on CANCER NURSING

ProgramEmbracing globalization through leadership

and partnership in cancer care

INTERNATIONAL CONFERENCE ON CANCER NURSING

CELEBRATING


ICCN 2016 INTERNATIONAL CONFERENCE

on CANCER NURSING

2

Full page 8-1/2" x 11"

CanCer nursing

One Subscription—Multiple Ways to Access CancerNursingOnline.com

Each bimonthly issue of CanCer nursing™ addresses the whole spectrum of problems arising in the care and support of cancer patients, such as:

Editor-in-Chief Pamela S. Hinds, PhD, RN, FAAN

5-K239

The Official Journal of the International Society of Nurses in Cancer Care

• prevention and early detection• geriatric and pediatric cancer nursing• medical and surgical oncology• ambulatory care• nutritional support

• psychosocial aspects of cancer• patient responses to all treatment

modalities• specific nursing interventions.

The journal offers unparalleled coverage of cancer care delivery practices worldwide, as well as groundbreaking research findings and their practical applications.

*2013 Journal Citation Reports® (Thomson Reuters, 2014)

Impact Factor: 1.931*

5-K239 NCC program ad ISNCC 4C.indd 1 4/16/15 1:07 PM


CanCer nursing




5-K239










CanCer nursing




5-K239









www.isncc.org

PROGRAMEMBRACING GLOBALIZATION THROUGH LEADERSHIP AND PARTNERSHIP IN CANCER CARE

3

TABLE OF CONTENTS

Welcome from the ISNCC President 4Welcome from the Conference Chair 5ICCN 2016 Official Partners 6ISNCC Leadership 9ISNCC Full & Association Members 10ISNCC Awards 11General Information 12Poster Awards & Scholarships 14Exhibits and Posters 14Supporter Acknowledgements 16Program 17Poster Listings 37About Our Supporters 45ISNCC Membership 51



on CANCER NURSING

4

WELCOME FROM THE ISNCC PRESIDENTDear Colleagues in Cancer Nursing,On behalf of the Board of Directors of the International Society of Nurses in Cancer Care (ISNCC), I welcome you to the 20th International Conference on Cancer Nursing (ICCN), the premier international educational opportunity for cancer nurses. We are so glad you are here to celebrate this landmark with us!The theme for the ICCN 2016 is ‘Embracing global-ization through leadership and partnership in cancer care.’ The ISNCC Conference Management Committee (CMC) worked incredibly hard to create a wonderful program that really drives home that the world is now smaller than ever, and we have unique opportunities to collaborate and build partnerships to promote ex-cellence in cancer care.ICCN offers a unique opportunity for us to come together and exchange ideas, especially on how nurses are leading the charge in cancer care in different countries, in their own unique way. It is also an opportu-nity for us to support each other as we engage in lead-ership roles and promote evidence-based practice. I am sure that you will agree that the wealth, breadth and depth of the program is an amazing representa-tion of all that cancer nurses are doing globally.We are also particularly pleased that we are continu-ing to offer joint sessions with our partners. Partner-ships within nursing and with other groups with shared goals build positive synergy and we will be discussing the many ways in which they help us move forward as a Society.

It is also our pleasure to welcome all of you to Hong Kong. We know that the conference offers a lot of choices, but we hope you will take at least a little time to enjoy this fascinating and vibrant city. Hopefully you will go for a walk and enjoy some of the diverse history and culture, and, of course, try some of the delicious food.Most importantly, we hope you will take advantage of every opportunity to network with colleagues from around the world. Nurses from over 30 countries are at ICCN and we challenge you to engage in conversation with a colleague from a country you are not familiar with, or even with someone from a different region in your own country that you may have never met before. This is the time to take advantage of our global village and establish some new partnerships!I would also like to invite you to continue collaborating with your international colleagues by joining ISNCC as an individual member. Please visit the ISNCC registra-tion desk during the conference and sign up for your membership.Welcome to the ICCN 2016 and wonderful Hong Kong!

Dr. Stella Aguinaga Bialous, RN, DrPH, FAAN ISNCC President

www.isncc.org


5

WELCOME FROM THE CONFERENCE CHAIRDear Cancer Nursing Colleagues,On behalf of the Conference Management Committee of the International Society of Nurses in Cancer Care (ISNCC), I welcome you to the International Confer-ence on Cancer Nursing 2016 (ICCN 2016) in Hong Kong, China! This conference marks the 20th time that ISNCC has held an international conference, and we are proud and excited to share the program and this unique op-portunity to meet with international cancer nurses with you! The Conference Management Committee has members from our international and regional partners and together we have planned a wonderful program that will expand your knowledge and enhance your ability to provide quality cancer care, develop inno-vative programs, provide cancer nursing education that is essential to healthcare’s future, and successfully conduct oncology nursing research.The theme for this year’s conference is “Embracing globalization through leadership and partnership in cancer care.” Presentations will focus on ways that oncology nurses provide leadership and partnership to make a difference in how cancer care is practiced, ensuring that patients and families receive the most up-to-date, evidenced-based care possible within our practice settings and that our educational institu-tions develop the foundation nurses need to provide the care patients need and deserve. Our goal is to share knowledge and experiences of leadership and partnering with others to provide quality cancer care across the globe.

I am particularly delighted to welcome you to Hong Kong, a city that never sleeps. The city is filled with fabulous tax-free shopping, exciting nightlife and thousands of eateries ranging from gourmet restau-rants to fun street stalls. Attend your selected ICCN 2016 sessions and then get out and enjoy all that Hong Kong has to offer. Take a ride on a tram, a ferry or the light rail to see the amazing tourist attractions or visit a park, walk along the beach or visit an outlying island. Enjoy a guided tour or self-guided walk – whatever you choose to enjoy this fabulous city!While at ICCN 2016, I hope you will take the oppor-tunity to network with other cancer nurses, share new experiences and information, and make and renew friendships. The meeting offers a wide variety of edu-cational opportunities including plenary speakers, oral and rapid fire presentations, instructional sessions, and poster sessions as well as social and cultural events. I invite you to enjoy this unique opportunity to meet and collaborate with cancer nurses from all over the world.Welcome to ICCN 2016 and the wonderful, cosmopol-itan city of Hong Kong!

Linda U. Krebs, PhD, RN, AOCN, FAANConference Management Committee, Chair



on CANCER NURSING

6

ICCN 2016 OFFICIAL PARTNERS

On behalf of the Asian Oncology Nursing Society (AONS), I welcome you to the International Conference on Cancer Nursing (ICCN) 2016 with an important theme ‘Embracing globalization through leadership and partnership in cancer care’. Cancer is a global health issue and cancer nurses play a vital role to lead and be a strong voice in the multi-disciplinary team. It is very crucial that cancer nurses worldwide partici-pate in this conference to learn and share knowledge with one another, and discuss how to deliver the best care for our cancer patients and their family. It is a great pleasure for AONS to work hand-in-hand with ISNCC on advancing knowledge and practice in cancer care through the ICCN 2016. We are very excited to be part of this global conference. We sincerely hope you will also join the AONS inter-national partner joint session on Wednesday 7th September 2016 from 1:50pm – 2:50pm. We will have three speakers to discuss the roles and challenges of nursing leadership in multidisciplinary cancer care. Please come and visit the AONS booth, chat with some of our board members, and learn more information about AONS, our official journal Asia-Pacific Journal of Oncology Nursing (APJON), and the 3rd AONS confer-ence to be held in September 2017 in Beijing. We wish you a fruitful and enjoyable conference in the vibrant city of Hong Kong!

Winnie So, PhD, RN President, AONS

On behalf of the Hong Kong College of Medical Nursing and Hong Kong Oncology Nursing Group, it is a great pleasure for me to welcome you all to the 20th anniversary ICCN 2016 in Hong Kong, one of the cities most vibrant with life and energy.

It is an honor for our organization to be a conference partner of ICCN 2016. Geographically and culturally speaking, Hong Kong is a key gateway to the mainland China. It serves as a bridge between the West and the East; thus a diverse blending of the western and the Chinese medical treatment. In this respect, we are very pleased to have a joint session titled ‘Enhance Quality of Oncology Care and Services Through Leadership and Collaborations’ conducted by the Chinese Nurses Association and HKCMN Oncology Nursing Group during the conference.

The theme “Embracing globalization through leadership and partnership in cancer care’” for ICCN 2016, highlights the issues addressing global cancer burden and the strong leadership from multiple partners being required to address multiple barriers to mitigate these ongoing global cancer disparities. We are pleased that many of our members will participate actively in the conference to share their knowledge. This is a tremendous opportunity for our members to meet international cancer nursing leaders from around the world, network on key cancer and oncology nursing issues, and make long-lasting professional connections.

It is a privilege for HKCMN and Hong Kong Oncology nurses to work hand-in-hand with ISNCC on advancing cancer care through ICCN 2016. We wish you an enjoyable and stimulating conference as well as a pleasant and memorable stay in Hong Kong!

Helena Li, RN, FHKANPresident, HKCMN

www.isncc.org


7

The European Oncology Nursing Society (EONS) is delighted to welcome delegates to the 2016 Interna-tional Conference on Cancer Nursing. The Internation-al Conference on Cancer Nursing (ICCN 2016) will be held in Hong Kong, China from September 4th through 7th, 2016. The theme for the conference is Embracing globalization through leadership and partnership in cancer care. The goal of the conference is to showcase ways in which cancer nurses provide leadership and create partnerships to promote quality cancer care around the globe.EONS as a professional organisation acts as a voice for cancer nursing across Europe and is an important partner in multi-organisational efforts to improve cancer care and patient outcomes. One of our major aims, in cooperation with our member Oncology Nursing Societies and other stakeholders, is to develop cancer nursing as a specialism in all European countries using a variety of different methods including research, education, clinical leadership, nursing strategy, advocacy, and policy development, together with improving the collaboration between countries to improve nursing roles in cancer care. We do so to meet future patient needs, improve cancer nursing as a career and profession and positively influence cancer patients’ treatment, their lives and their future.We are really excited to be part of this global confer-ence and look forward to working together with our cancer nursing colleagues from across the world to strengthen collaboration.We very much hope that you will join the EONS session on Wednesday, 7 September, 2016 “Enhancing Rec-ognition of the Nursing Contribution to Cancer Care: Current Challenges and Solutions in Europe” and we hope to meet and exchange experiences with you at the EONS stand. We wish you a very productive and successful conference.

Daniel Kelly, PhD, MSc, BSc, RN, FRCNPresident, EONS

Dear ICCN Conference Participants,On behalf of the International Psycho-Oncology Society (IPOS), I offer welcome greetings for your con-ference in Hong Kong, China, 4 - 7 of September, 2016. With IPOS members from more than 60 countries, we applaud your conference theme of Embracing global-ization through leadership and partnership in cancer care.Leadership and partnership are shared themes and identified strategic priorities for IPOS. As an organi-zation in official relations with the World Health Or-ganization (WHO) we continue to advocate towards adoption of our Standard of Care and adoption of Clinical Practice Guidelines in Cancer Care which state:• Psychosocial cancer care should be recognized as

a universal human right;• Quality cancer care must integrate the psychoso-

cial domain into routine care;• Distress should be measured as the sixth vital sign

after temperature, blood pressure, pulse, respira-tory rate and pain.

As nursing professionals, you are essential, valued members of healthcare teams addressing the psycho-social aspects of cancer. We support your continued professional development and we offer you best wishes for an engaging, fruitful conference.Best regards,

Luzia Travado, PhDHead of Psycho-OncologyChampalimaud Clinical Centre, Lisboa, PortugalPresident, International Psych-On-cology Society (IPOS)



on CANCER NURSING

8

The Multinational Society of Supportive Care in Cancer (MASCC) is pleased to be partnering with the Interna-tional Society of Nurses in Cancer Care by presenting a plenary session in the International Conference on Cancer Nursing in Hong Kong. The focus of MASCC is that supportive care is the key to making excellent cancer care possible. Cancer nurses spend much of their time delivering excellent supportive care. Many of the sessions in this meeting are highly relevant to both Societies. Supportive care spans the spectrum of cancer care from diagnosis, through treatment and then survivorship and palliative care. Supportive care embraces both the management of the side effects of cancer treatment as well as the symptoms of cancer. Research has been important in delivering more effective means of treating some side effects such as vomiting or developing neutropenia after therapy. Other side effects such as dyspnea and fatigue are proving more challenging. The psychosocial and spiritual issues faced by cancer survivors are important to address to ensure an ongoing maximization of quality of life.The joint plenary session will explore the emerging field of the management of peripheral neuropathy after chemotherapy as well as examining the oncology nurse’s role in delivering survivorship care.We trust that you will find this session valuable and look forward to further sharing our supportive care interests in the future.

Professor Ian Olver, AM, MD, PhDMASCC President

Welcome from CNA!

Dear Friends and Colleagues,On behalf of the Chinese Nurses Association we are happy to welcome you to ICCN 2016 in beautiful Hong Kong!We take great pleasure in inviting you to attend the Plenary Session co-hosted by the Chinese Nurses As-sociation and Hong Kong Oncology Nursing Group.The theme of this session is “Enhance quality of oncology care and services through leadership and collaborations”. It is our honor to have Professor Suzanne So-Shan Mak and Dr. Yong-Yi Chen share in-formation with us about their amazing achievements and opinions on this topic. We look forward to this session offering you the most up-to-date scientific dis-coveries and practices, and a chance to share the latest experiences and advancements in the field.It is a great pleasure to be able to host such a fabulous session at the 20th ICCN. Hong Kong is one of the most attractive and modern cities in the world. We wish you a successful conference and a truly rewarding week in Hong Kong.Sincerely,

Bo XuDirector of Oncology Nursing Committee, Chinese Nurses Association

www.isncc.org


9

ISNCC LEADERSHIP

Board of Directors

President: Stella Bialous, USAPresident Elect: Patsy Yates, AustraliaSecretary/Treasurer:

Janice Stewart, CanadaCommunications Portfolio:

Yongyi Chen, ChinaConference Management Portfolio:

Linda Krebs, USACorporate and Philanthropic

Development Portfolio: Annie Young, United Kingdom

Knowledge Development and Dissemination Portfolio: Susan Beck, USA

Member Development Portfolio: Andrew Dimech, United Kingdom

Policy Portfolio: Yael Ben Gal, Israel

Awards and Nominations Committee

CHAIR: GRETA CUMMINGS, CANADASusan Beck, USAStella Bialous, USAAndrew Dimech, United KingdomEsther Green, CanadaCatherine Johnson, AustraliaTish Lancaster, AustraliaWinnie So, China

Communications Committee

CHAIR: YONGYI CHEN, CHINACynthia Abarado, USALili Hou, ChinaCatherine Johnson, AustraliaDaniel Kelly, United KingdomKyung Hee Lim, KoreaLing Wai Man, ChinaJoshua (Ngwang) Menang, CameroonJane Phillips, AustraliaMember Development Liaison:

Andrew Dimech, United Kingdom

Conference Management Committee

CHAIR: LINDA KREBS, USAEva Gallagher, USAVioleta Lopez, SingaporeDonna Milne, Australia Paranee Phongnopakoon, ThailandWinnie So, ChinaMarise Dutra Souto, BrazilLeanne Stone, AustraliaAnnie Young, United KingdomAONS Representative:

Yeur-hur Lai, TaiwanAONS Representative:

Sui-whi Jane, TaiwanChinese Nurses Association

Representative: Zhenqi Lu, ChinaEONS Representative: Mary Wells,

United KingdomHong Kong Oncology Nursing Group

Representative: Suzanne Mak, ChinaIPOS Representative:

Wendy Lam, ChinaMASCC Representative:

Alex Molasiotis, China

Corporate and Philanthropic Development Committee

CHAIR: ANNIE YOUNG, UNITED KINGDOMSusan Cruickshank, United KingdomJulia Downing, UgandaCatherine Johnson, AustraliaElaine Lennan, United KingdomAirong Lu, ChinaKevin Schreffler, USANwozichi Chinomso Ugochukwu, Nigeria

Finance and Audit Committee

CHAIR: JANICE STEWART, CANADAStella Bialous, USACatherine Johnson, AustraliaLinda Krebs, USAPatsy Yates, AustraliaAnnie Young, United Kingdom

Knowledge Development and Dissemination Committee

CHAIR: SUSAN BECK, USAJulia Downing, UgandaRehana Elahi, PakistanJeanne Marie Erickson, USACatherine Johnson, AustraliaLuís Carlos Lopes Júnior, BrazilTish Lancaster, AustraliaAyda Gan Nambayan, PhilippinesShiow-Ching Shun, TaiwanAllison Steinberg, USAPolicy and Advocacy Liaison:

Yael Ben Gal, Israel

Member Development Committee

CHAIR: ANDREW DIMECH, UNITED KINGDOMMajeda Afeef Al-Ruzzieh, JordanLuz Esperanza Ayala de Calvo, ColombiaMarlon Garzo Saria, USAMary Glavassevich, CanadaCatherine Johnson, AustraliaJudi Johnson, USATish Lancaster, AustraliaMassey Nematollahi, CanadaWang Qi, ChinaMegan Rogers, AustraliaErik van Muilekom, The NetherlandsCommunications Liaison:

Yongyi Chen, China

Policy and Advocacy Committee

CHAIR: YAEL BEN GAL, ISRAELStella Bialous, USAGeorgie Cusack, USA Anne-Marie Dewar, AustraliaRebecca Doherty, SwitzerlandMargaret Fitch, CanadaEva Gallagher, USACatherine Glennon, USAVirginia LeBaron, USAJane Marsh, AustraliaJane Phillips, AustraliaPatsy Yates, Australia



on CANCER NURSING

10

ISNCC FULL MEMBERS

AustraliaCancer Nurses Society of Australia (CNSA)

BrazilBrazilian Oncology Nursing Society (SBEO)

CanadaCanadian Association of Nurses in Oncology (CANO-ACIO)

ChinaOncology Nursing Committee of Chinese Nursing Associations

DenmarkDanish Cancer Nursing Society (FSK)

FranceFrench Oncology Nurses’ Society (AFIC)

IcelandIcelandic Oncology Nursing Society

IndiaThe Oncology Nurses Association of India

JapanJapanese Society of Cancer Nursing

Netherlands

The Netherlands Nursing Oncology Society (V & VN Oncology)

New Zealand The Cancer Nurses College

PortugalPortuguese Oncology Nursing Association (AEOP)

Singapore Singapore Nurses Association

South KoreaKorean Oncology Nursing Society (KONS)

Taiwan Taiwan Oncology Nursing Society

Turkey Turkish Oncology Nursing Society

United Kingdom

UK Oncology Nursing Society (UKONS)

USA Oncology Nursing Society (ONS)

ZimbabweHospice & Palliative Care Associa-tion of Zimbabwe

ISNCC ASSOCIATION MEMBERS Australia Gold Coast University Hospital

Australia Icon Cancer Care

Australia Westmead Cancer Care Centre - Westmead Hospital

Ghana National Center for Radiotherapy and Nuclear Medicine, Korle-Bu Teaching Hospital

Israel Israel Oncology Nursing Society

Japan The Jikei University School of Nursing

Japan Tokyo Medical University

Taiwan Chang Gung University of Science and Technology

Taiwan Taipei Veterans General Hospital

Taiwan Taichung Veterans General Hospital

Thailand Mahidol University

USA Moffitt Cancer Center

USA UAB School of Nursing

Zambia Zambia Oncology Nurses Society

www.isncc.org


11

ISNCC AWARDS

Robert Tiffany Lectureship

This Lectureship was created to commemorate Robert Tiffany, the founding member and President of the Inter-national Society of Nurses in Cancer Care. Robert Tiffany was the initiator of the Biennial International Confer-ence on Cancer Nursing. The 2016 ICCN marks the 20th Conference - a significant milestone for ISNCC and a testament to his legacy. Robert Tiffany was an inspiration to nurses around the world. The intention of the named lecture is to honour those who have a similar capacity to inspire cancer nurses of today and of the future.

Myrna Myrna McLaughlin-Anderson is a Senior Advisor in the Panama Ministry of Health and has almost thirty years of experience in cancer nursing. She is also a Professor of Nursing at the Uni-versity of Panama, where she teaches

several pre-graduate and post-graduate courses in the School of Nursing including Adult Health, Cancer Prevention and Epidemiology, Chemotherapy and Palliative care. In 2008, she the received ISNCC’s Past Presidents’ Award in recognition of the development of Asociación Hospes Pro Cuidado Paliativo, a pallia-tive care program in Panama. From 2009-2011, Myrna was the advisor to the Vice-Minister of Health. From that position, she was an integral component of the commission that developed the National Program of Palliative Care and the National Plan for Cancer Pre-vention and Control. In 2013, the Mayor of the City of Panama awarded Myrna the Key of the City in rec-ognition of her career treating cancer patients and promoting cancer nursing education.

Distinguished Merit Award

The ISNCC Distinguished Merit Award is given in rec-ognition of an outstanding member who has contrib-uted to the international advancement of the science and art of cancer nursing.Professor Sanchia Aranda is the CEO of Cancer

Council Australia. She has more than 30 years’ experience in cancer control as a clinician, researcher, educator and senior healthcare administrator. She has extensive experience in health-sys-tem administration and most recently

was Director of Cancer Services and Information and Deputy CEO at the Cancer Institute New South Wales.Professor Aranda is President-Elect of the Union for

International Cancer Control (UICC) and a former President of ISNCC. As well as being a research fellow at the Peter MacCallum Cancer Centre, she holds academic appointments at the School of Health Sciences, University of Melbourne, and the Faculty of Nursing, University of Sydney.Widely published in Australian and international health literature, Professor Aranda has also conducted research reviews for the National Health and Medical Research Council, Australian Research Council, Cancer Councils, state nursing boards and private sector research funding bodies. As CEO of Austra-lia’s top non-government cancer control organization, Professor Aranda is a strong independent voice on evidence-based cancer control. She is engaged in all fields of cancer from primary prevention through to survivorship and advanced care, and has a particular professional interest in improved ways to care for and support cancer patients.

Past Presidents’ Award

The ISNCC Past Presidents’ Award is given in recog-nition of a cancer nurse from a low resource country who has initiated and sustained a program of cancer care in her/his country that has been in place for three or more years and has the potential for replication of adaptation beyond the country’s borders.

Naomi Oyoe Ohene Oti has been working in the field of oncology for the past fourteen years. She leads oncology nursing training at the National Centre for Radiotherapy and Nuclear Medicine in Korle Bu, Ghana. She has been pivotal in oncology nursing education at

her facility and in Ghana. In 2002 Naomi travelled to the Mayo Clinic in the USA where she was trained in the co-ordination of clinical trials. In this role, she identified and learned the critical role of the oncology nurse and its impact on delivery of quality care to cancer patients. The Mayo program inspired her to pursue formal training in oncology. Naomi used her training to institute a variety of in-house training programs that have enabled nurses to deliver quality cancer care. Naomi is now the focal person for oncology nursing training for Ghana’s Ministry of Health. In 2014 and 2015 she was among a team of specialists who developed the Postgraduate Clinical Oncology Nurse Specialist curriculum for the Ghana College of Nurses and Midwives. Naomi was also a recipient of an ISNCC conference scholarship to the 13th ICCN in Sydney, Australia.



on CANCER NURSING

12

GENERAL INFORMATION

Venue

Sheraton Hong Kong Hotel & Towers • 20 Nathan Road, Kowloon, Hong Kong • Phone: 852.2369.1111

THIRD FLOOR

PREFUNCTION AREA

1. TANG1a. TANG II1b. TANG I2. SECRETARIAL 1 3. SECRETARIAL 2

1

1b

1a

2

3GRAND BALLROOM

A B C

FOURTH FLOOR

SUNG II

SUNG I

SUNG 1. MING 1a. MING II 1b. MING I 2. MING TERRACE 3. CHING4. CHING TERRACE

11b1b

2

3

4

1a

1b

www.isncc.org


13

Included In Your Registration Fee

Full-conference registered attendees receive:

• Access to all Scientific and Concurrent Sessions• Access to Posters and Exhibits• Program Materials• Admission to the Welcome Reception • Food and Beverages, including:

Lunch at Corporate Symposia Hors d’oeuvres and one drink ticket for the

Welcome Reception Break refreshments

Exhibit-only attendees receive:• Access to Posters and the Exhibit Hall

Registered guests receive:• Access to Posters and the Exhibit Hall • Access to the Welcome Reception

Registration

The Registration Desk is located in the Tang Foyer.Registration hours are as follows:

Saturday, September 3, 2016 5.00pm – 7.00pmSunday, September 4, 2016 8.00am – 7.30pmMonday, September 5, 2016 7.00am – 6.30pmTuesday, September 6, 2016 7.00am – 6.30pmWednesday, September 7, 2016 7.00am – 4.00pm

Mentor Program:

The Mentor Program provides a detailed orientation for first time delegates attending the ICCN. Mentors will describe the meeting in general, how to interpret the conference program, how to best work out which sessions to attend, and how to benefit from the poster sessions, as well as practical matters such as meal breaks and what to expect from social functions. Mentees may be introduced to colleagues who work in similar areas of specialty and be advised of how to network with cancer nursing professionals from around the globe.A “Meet your Mentor” session is scheduled for Monday, September 5 from 7.00am – 8.00am in Ballroom A for mentors and mentees to connect.

Continuing Education Credit Information:

ISNCC is approved by the California Board of Registered Nursing, Provider Number 16617, for a maximum of 21.85 Contact Hours. Continuing education credits are offered for the preconference workshops, plenary and concurrent abstract sessions. In order to received credit, participants must attend at least one session and fill out the online record of attendance and evaluation forms. Certificates will be emailed within 6 - 8 weeks of the conference.

Speaker Services Centre

The Speaker Services Centre, located in the Group Lounge, is equipped with laptop PC computers for all faculty members to review their presentations before their sessions. To better serve you, your presentation should be uploaded at least 24 hours prior to your session. It can be previewed up to 3 hours prior to your session.The Speaker Services Centre hours are as follows:

Sunday, September 4, 2016 8.00am – 7.30pmMonday, September 5, 2016 7.00am – 6.30pmTuesday, September 6, 2016 7.00am – 6.30pmWednesday, September 7, 2016 7.00am – 3.00pm

Language

The official language of the Conference is English.

Abstract Book

Oral and poster abstracts will be published in the ISNCC Cancer Nursing abstract supplement alongside the November/December issue.The abstracts to be included in the Abstract Supplement will be published as they were submitted by the authors. The ICCN 2016 Conference Management Committee has not altered the submissions for inclusion. Author’s credentials have been included where submitted.

Certificates of Attendance

You will receive an electronic Certificate of Attendance 4 - 6 weeks after the meeting.



on CANCER NURSING

14

POSTER AWARDS & SCHOLARSHIPS

People’s Choice Poster Award

The People’s Choice Poster Award is your chance to select the poster you feel is the best during each poster session. Each ICCN participant has the opportunity to take part in the selection of the daily People’s Choice Award. This award can be given to any poster presented in that day’s Poster Session regardless of category or topic. You will receive specially marked cards in your delegate badge that allow you to vote once for each Poster Session on Monday, September 5, Tuesday, September 6 and Wednesday, September 7. Votes will be tallied at the end of each day. The People’s Choice Award winners’ names will be announced and they will receive a certifi-cate of award at the beginning of the Plenary Session the following day or at the Closing Session.

Poster Award

Each day, awards will be given for the best poster, one for the category of Research and the other for all Non-Research. A team of judges fluent in both English and Mandarin along with a coordinator will evaluate the top 10 ranked posters for each grouping (research and

non-research) on each day based on scores given during the abstract review process. The poster award-winners will be announced at the Closing Session.

Conference Scholarship

The ISNCC Conference Scholarships were awarded to graduate or post-graduate students from underserved population groups or those working with underserved population groups in the Asia-Pacific region to offset the costs associated with travelling to ICCN 2016. These scholarships were chosen by the ISNCC Awards and Nominations Committee. CONGRATULATIONS TO:

ARIESTA MILANTIFaculty of Nursing, University of Indonesia; Jatinegara Community Health Centre, Jakarta Timur, IndonesiaFAUZIA PESNANIZiauddin Cancer Hospital, Karachi, PakistanYUE WANGNursing School of the Fourth Military Medical University, Xi’an, China

EXHIBITS AND POSTERS

Poster Move In and Move Out Hours

POSTER SESSION 1 POSTER SESSION 2 POSTER SESSION 3

Move In Time

Sunday, September 4, 20163.00pm – 4.00pm

Monday, September 5, 20166.00pm – 6.30pmPlease have your poster displayed before 7.30am on Tuesday, September 6

Tuesday, September 6, 20166.30pm-8.30pm Please have your poster displayed before 7.30am on Wednesday, September 7

Presentation Hours

Sunday, September 4, 20165.50pm – 7.40pmMonday, September 5, 201610.30am – 10.50am1.20pm – 1.50pm4.20pm – 4.40pm

Tuesday, September 6, 201610.30am – 10.50am1.20pm – 1.50pm4.20pm – 4.40pm

Wednesday, September 7, 201610.30am – 10.50am1.20pm – 1.50pm

Move Out Time

Monday, September 5, 20165.00pm – 6.00pm

Tuesday, September 6, 20165.30pm-6.30pm

Wednesday, September 7, 20162.00pm-3.00pm

www.isncc.org


15

The Exhibit Hall and Posters are located in Tang and the Tang Foyer.Posters are a wonderful educational opportunity at this conference. The Conference Management Committee received a wealth of abstracts on research, education, management and clinical practice. For your conve-nience the posters will be profiled each day, where delegates can “Meet the Authors”. During these sessions, authors will be present to discuss their work with you. Posters will be individually numbered and grouped by themes within the poster hall.

Exhibit Booths

BARD 08

Dale Medical Products, Inc. 05

End-of-Life Nursing Education Consortium (ELNEC)

07

Pfizer Oncology 06

Roche 03

Teva Pharmaceuticals LTD. 04

Exhibit Table Tops

Asian Oncology Nursing Society (AONS) 10

European Oncology Nursing Society (EONS)

01

ICU Medical 09

International Psycho-Oncology Society (IPOS)

12

NCI Center for Global Health 02

Oncology Nursing Society (ONS) 11

01

02

03 04 05 06

09 10 11 12

07 08

Exhibit Hours

Exhibits are located in Tang.Sunday, September 4, 2016 5.50pm – 7.40pmMonday, September 5, 2016 10.20am – 4.50pmTuesday, September 6, 2016 10.20am – 4.50pmWednesday, September 7, 2016 10.20am – 2.00pm



on CANCER NURSING

16

SUPPORTER ACKNOWLEDGEMENTSThe International Society of Nurses in Cancer Care (ISNCC) wishes to acknowledge the support of all of the companies and organizations who contributed generously to the 2016 International Conference on Cancer Nursing (ICCN).

Gold Level Supporter

Bronze Level Supporter

Symposia and Tutorials

Preconference Workshops

Conference Scholarship Supporters

ISNCC would also like to thank its individual donors for support of the conference scholarships:

NCI Center for Global Health

• Susan Beck • Stella Bialous • Rebecca Chenery

• Linda Krebs• Myungsung Li• Airong Lu

• Albert Luppens• Pam Malloy • Megan Nutt

• Winnie So • Bo Xu

• Asian Oncology Nursing Society • Cancer Nurses Society of Australia • Oncology Nursing Society

We would also like to thank the following organizations for their generous support:

www.isncc.org


17

PROGRAMFriday 2 September 2016

7.00pm – 9.00pm ISNCC EXECUTIVE COMMITTEE MEETING*

Saturday 3 September 2016

9.00am – 5.00pm ISNCC BOARD OF DIRECTORS MEETING – DAY 1* Ching

5.00pm – 7.00pm Conference Registration Open Tang Foyer

7.00pm – 9.00pm ISNCC BOARD OF DIRECTORS DINNER WITH CONFERENCE MANAGEMENT COMMITTEE*

Offsite

Preconference and Welcome: Sunday 4 September 2016

Fruit and pastries provided. Ballroom Foyer

8.00am – 7.30pm Conference Registration Open Tang Foyer

8.00am – 7.30pm Speaker Services Open Group Lounge

9.00am – 5.00pm ISNCC BOARD OF DIRECTORS MEETING – DAY 2* Ching

9.00am – 4.00pm PRECONFERENCE WORKSHOP 1 – END-OF-LIFE NURSING EDUCATION CONSORTIUM***Hosted by End-of-Life Nursing Education Consortium (ELNEC)

Sung

SPEAKERS: PAM MALLOY, USA, JUDITH PAICE, USA AND CHERYL ANN THAXTON, USA

The End-of-Life Nursing Education Consortium (ELNEC) project is a national education initiative to improve palliative care through education. During the 16 years of this project, over 20,700 nurses and other healthcare professionals, representing all 50 states, plus 88 international countries have received ELNEC training. During this 1-day course, you will receive education on palliative care related to pain and symptom management, communication, loss/grief/bereavement, and final hours of life. You will also receive a flash drive housing the entire 2016 ELNEC-Core curriculum so you can take this education back to your institution and educate others. For more information about ELNEC, go to www.aacn.nche.edu/ELNEC

9.00am – 12.00pm PRECONFERENCE WORKSHOP 2 – GLOBAL ISSUES OF SURVIVORSHIP***Hosted by ISNCC, CANO-ACIO and ONS

Ming

SPEAKERS: SUSAN M. SCHNEIDER, USA, TRACY TRUANT, CANADA, MARY WELLS, UNITED KINGDOM, TOMOKO IZAWA, JAPAN, RAY CHAN, AUSTRALIA AND DEBORAH WALKER, USA

Global Perspectives on Cancer Survivorship, hosted by the Oncology Nursing Society (ONS), the Canadian Association of Nurses in Oncology (CANO-ACIO) and the International Society of Nurses in Cancer Care (ISNCC), will address major topics associated with nursing management of cancer survivorship including: 1) the history, influences and primary definitions of cancer survivorship; 2) development, use and controversies of cancer survivorship care plans; and 3) managing cancer survivorship across the globe.

* By invitation only ***Pre-registration required

http://www.aacn.nche.edu/ELNEC

http://www.aacn.nche.edu/ELNEC



on CANCER NURSING

18

Preconference and Welcome: Sunday 4 September 2016

10.00am – 12.00pm PRECONFERENCE WORKSHOP 3 – TRADITIONAL CHINESE MEDICINE (MANDARIN)CHAIRS: KIM-HUNG LEE, CHINA AND MANDY SAU-MAN, CHINA

Ballroom A

The Nine Body Constitutions in Chinese Medicine and Acupressure for Symptom Management for Patients with Cancer

SPEAKER: WAI-LING LIN, CHINA

1.00pm – 4.00pm PRECONFERENCE WORKSHOP 4 – PUBLISHING WORKSHOP*** Hosted by the European Journal of Oncology Nursing

Ming

SPEAKER: ALEX MOLASIOTIS, CHINA

This session will focus on taking participants through the publication process, from identifying the reasons for writing to having an article published, and highlight some major mistakes people often make, particularly those less experienced researchers, in their attempt to disseminate their piece of work. Some ‘tips’ for preparing papers for submission for publication, based on editorial experiences of many years, will also be shared in order to help participants increase their publication success.

12.00pm – 4.00pm EXHIBIT AND POSTER SESSION 1 MOVE INExhibitors Move In: 12.00pm – 4.00pmPoster Session 1 Move In: 3.00pm – 4.00pm

Tang & Tang Foyer

2:00pm – 4:00pm PRECONFERENCE WORKSHOP 5 - TRADITIONAL CHINESE MEDICINE (ENGLISH)CHAIRS: KIM-HUNG LEE, CHINA AND MANDY SAU-MAN, CHINA

Ballroom A

The Nine Body Constitutions in Chinese Medicine and Acupressure for Symptom Management for Patients with Cancer

SPEAKER: WAI-LING LIN, CHINA

5.50pm – 7.40pm EXHIBITS AND POSTER SESSION 1 OPEN Tang & Tang Foyer

6.00pm – 7.30pm WELCOME RECEPTION WITH EXHIBITS AND POSTER SESSION 1Come join us for a drink and hors d’oeuvres to celebrate the opening of the 20th ICCN!

6.30pm Welcome Remarks SPEAKERS: STELLA BIALOUS, USA AND LINDA KREBS, USA

Tang & Tang Foyer

Conference Day 1: Monday 5 September 2016

Fruit and pastries provided. Ballroom Foyer



7.00am – 8.00amISNCC POLICY AND ADVOCACY COMMITTEE MEETING

Business Centre

ISNCC KNOWLEDGE DEVELOPMENT AND DISSEMINATION COMMITTEE MEETING

Ching


www.isncc.org


19


7.00am – 8.00am MEET YOUR MENTOR Ballroom A

8.00am – 9.00amOFFICIAL OPENING AND KEYNOTE Ballroom BC

8.00am – 8.05amGREETINGS BY ISNCC CMC CHAIR

LINDA KREBS, USA

8.05am – 8.15amWELCOME ADDRESS BY ISNCC PRESIDENT

STELLA BIALOUS, USA

8.15am – 8.25 am OPENING CELEBRATIONS BY LION DANCERS

8.25am – 9.00amROBERT TIFFANY LECTURESHIP AND KEYNOTE ADDRESSCHAIR: STELLA BIALOUS, USASupported by Royal Marsden Trust

Building Capacity for Cancer Care, While Facing Global Challenges and Transferring Knowledge

SPEAKER: MYRNA MCLAUGHLIN DE ANDERSON, PANAMA

Ballroom BC

9.10am – 10.30amConcurrent Sessions

CONCURRENT SESSION A1: CULTURAL DIVERSITYCHAIR: CARLA REMONDINI, USA

Ballroom BC

9.10am – 9.25amOE-1. Demographic Predictors of Breast Cancer Screening Behaviors Among Immigrant Women in Australia

CANNAS KWOK, AUSTRALIA

9.25am – 9.40amOE-2. The Impact of Chemotherapy on Patients >65 Years

CAROLE FARRELL, UNITED KINGDOM

9.40am – 9.55amOE-3. Validation of Breast Cancer Screening Beliefs Questionnaire in Five Versions

CANNAS KWOK, AUSTRALIA

9.55am – 10.10amOE-4. If it Works Here, We Can Make it Work There! Flexibility is Key to Diverse Education

ANET JULIUS, CANADA

10.10am – 10.25amOE-5. Closing the Gap: Implementation of a National Cancer Nurse Coordination Program

NATALIE JAMES, NEW ZEALAND


CONCURRENT SESSION A2: CARE DELIVERY – 1CHAIR: ELAINE LENNAN, UNITED KINGDOM

Ballroom A

9.10am – 9.25amOE-6. A Nurse-Led, Immunotherapy Telephone Assessment Service to Improve Waiting Times

JOANNE UPTON, UNITED KINGDOM

9.25am – 9.40amOE-7. Examining the Role of the Advanced Nurse Practitioner within an Oncology Clinical Trials Service

MICHELLE DAVIES, UNITED KINGDOM

9.40am – 9.55amOE-8. Impact Evaluation of Integrated Holistic Care Model for Cancer Patients Receiving Chemotherapy

PENSUPA SRIJARAT, THAILAND



on CANCER NURSING

20


9.10am – 10.30amConcurrent Sessions 9.55am – 10.10am

OE-9. Nurse Led Clinic for Head and Neck Cancer Patients on Chemotherapy Treatment – A New Service

DEBRA FARRELL, AUSTRALIA

10.10am – 10.25amOE-10. An Emerging Service Model: In Patient Clinical Care Manager (IPCCM) for Cancer Patient

KAM SHING HO, CHINA


CONCURRENT SESSION A3: HEALTH PROMOTIONCHAIR: VIOLETA LOPEZ, SINGAPORE

Sung

9.10am – 9.25amOE-11. The Eastern Europe Nurses’ Centre of Excellence for Tobacco Control: A Multinational Project

STELLA BIALOUS, USA

9.25am – 9.40amOE-12. Nurses Handling Cytotoxic Drugs is Critical: Outcomes of a 20-Year Follow Up Study

ANNA TOMPA, HUNGARY

9.40am – 9.55amOE-13. Educating the Leukemia Population

KAMINIBEN PATEL, CANADA, CHRISTINE BENT, CANADA AND SANDRA BOLYKI, CANADA

9.55am – 10.10amOE-14. Successful Measures in Prevention of Oncology In-Patient Suicide in QMH of HK

KITHELIA LAI, CHINA

10.10am – 10.25amOE-15. Development of Training Curriculum in Sexual Health for the Postoperative Breast Cancer Patients

PEI-PEI WU, CHINA


INSTRUCTIONAL SESSION A4: GLOBAL PARTNERSHIPS ENHANCE PALLIATIVE CARE AND ONCOLOGY EDUCATION FOR NURSESCHAIR: DEBORAH WALKER, USA

SPEAKERS: DEBORAH WALKER, USA, MARIE BAKITAS, USA AND REBECCA SIPPLES, USA

Learning Objectives:1. Describe the methods that have enhanced palliative care and oncology

curricula for nurses in Malawi, Turkey and Alabama, USA.2. Describe resulting sustainable global partnerships in research,

education and practice.

Ching

10.20am – 4.50pm EXHIBITS AND POSTER SESSION 1 OPEN Tang & Tang Foyer

10.30am – 10.50am Coffee/Tea Break with Exhibits and Poster Session 1 Tang & Tang Foyer

10.50am – 12.10pm Concurrent Sessions

CONCURRENT SESSION B1: PALLIATIVE & END OF LIFE CARE – 1CHAIR: JANE PHILLIPS, AUSTRALIA

Ballroom BC

10.50am – 11.05amOE-16. The Burden of Decision Making Regarding the Place of End-of-Life Cancer Care on Bereaved Families

SENA YAMAMOTO, JAPAN

www.isncc.org


21



11.05am – 11.20amOE-17. Perspectives on Providing Spiritual Care

MARGARET FITCH, CANADA

11.20am – 11.35amOE-18. Transitions in Palliative Treatment: A Patient and Family Experience

JOHANNA MAREE, SOUTH AFRICA

11.35am – 11.50amOE-19. Spiritual Needs of Patients with Advanced Cancer in China

CHANG TIAN, CHINA

11.50am – 12.05amOE-20. Meeting the Palliative Care Needs of Patients: Barriers for Nurses in Nigeria

ADENIKE ONIBOKUN, NIGERIA


CONCURRENT SESSION B2: QUALITY & SAFETYCHAIR: LETITIA LANCASTER, AUSTRALIA

Ballroom A

10.50am – 11.05amOE-21. Full Nursing Management of Breast Cancer after PICC Catheter Evaluation

RONG YAN, CHINA

11.05am – 11.20amOE-22. Feasibility of Using Small Innovative Team Approach to Engage Oncology Nurses and Improve Quality

KITHELIA LAI, CHINA

11.20am – 11.35amOE-23. Cause Analysis and Nursing Countermeasures for Late Complications in Oncologic Patients with TIVAPS

XINYAN YU, CHINA

11.35am – 11.50amOE-24. Chinese Nurses’ Experience Regarding Disclosure of Medication Error to Patients and Family Members

FENGQI DONG, CHINA

11.50am – 12.05amOE-25. Proactive Intentional Round to Reduce Falls – A New Fall Prevention Initiative in the Oncology Wards

SAU YEE CHAN, CHINA


CONCURRENT SESSION B3: SURVIVORSHIP -1CHAIR: DONNA MILNE, AUSTRALIA

Sung

10.50am – 11.05amOE-26. Effectiveness of Adventure-Based Training in Reducing Fatigue among Childhood Cancer Survivors

KA YAN HO, CHINA

11.05am – 11.20amOE-27. Yoga & Head and Neck Cancer

SHEILA RIDNER, USA

11.20am – 11.35amOE-28. Implementing a New Programme of Follow Up after Treatment for Colorectal Cancer in the UK

JANE WINTER, UNITED KINGDOM



on CANCER NURSING

22


10.50am – 12.10pm Concurrent Sessions 11.35am – 11.50am

OE-29. Evaluating Sexual Nursing Intervention for Cervical Cancer Survivors in Indonesia

ARIESTA MILANTI, INDONESIA

11.50am – 12.05amOE-30. Psychometric Performance of a Chinese Version of the FSFI in Cervical Cancer Patients

HUAYUN LIU, CHINA

10.50am - 11.50amConcurrent Sessions

CONCURRENT SESSION B4: RAPID FIRE – ENGLISHCHAIR: LINDA KREBS, USA

Ching

10.50am – 11.00amRF-E-1. A Written Handing-Over-Tool for Nurses: Educational Development

SANGEETHA SAMUEL, INDIA

11.00am – 11.10amRF-E-2. Quality of Life of Breast Cancer Young Women in the Republic of Panama

MYRNA MCLAUGHLIN DE ANDERSON, PANAMA

11.10am – 11.20amRF-E-4. Nurse’s Role in Declotting Thrombotic Occlusion via Implanted Port in Ramathibodi Hospital

SUWANNEE SIRILERTTRAKUL, THAILAND

11.20am – 11.30amRF-E-6. Delays in Elective Chemotherapy Administration

CELIA DIEZ DE LOS RIOS DE LA SERNA, UNITED KINGDOM

11.30am – 11.40amRF-E-7. Analysis of the Present Situation and Influence Factors on Smoking Control of Lung Cancer Patients

MIAO LIU, CHINA

11.40am – 11.50amRF-E-9. Implementation of Focused Educational Program to Enhance CBAD-Related Occlusion Care

WOAN TYNG LOOI, SINGAPORE

12.20pm – 1.20pm CORPORATE LUNCH TUTORIAL SESSIONSupported by NCI Center for Global Health

Update on Oncology Nursing Education and Leadership Efforts in LMICs Session

PRESENTERS: ANNETTE GALASSI, RN, MA, OCN, NURSE CONSULTANT (CONTRACTOR), NCI CENTER FOR GLOBAL HEALTH; STELLA BIALOUS, RN, PHD

Learning Objectives:• to describe results of a study of U.S. NCI Comprehensive Cancer

Center about global activities in cancer nursing education and training• to identify ways in which information about global activities in cancer

nursing education and training can be obtained from countries outside the U.S.

• to identify potential mechanisms for sharing this information • to discuss progress to date on the oncology nursing leadership and

education in low and middle-income countries project • to discuss next steps

Ballroom BC

1.20pm – 1.50pm Coffee/Tea Break with Exhibits and Poster Session 1 Tang & Tang Foyer

www.isncc.org


23


1.50pm – 2.50pmPLENARY SESSION I: ENHANCE QUALITY OF ONCOLOGY CARE AND SERVICES THROUGH LEADERSHIP AND COLLABORATIONSChinese Nurses Association and Hong Kong Oncology Nursing Group Regional Partners Joint Session

CHAIR: CARENX WAI-YEE LEUNG, CHINA

How Quality of Oncology Care and Services can be Improved Through Leadership and Collaborations: Cross-Clusters CQI Program in Hong Kong

SPEAKER: SUZANNE SO-SHAN MAK, CHINA

Developing an Evaluation Index System to Assess Patients’ Satisfaction with Oncology Care and Services

SPEAKER: YONGYI CHEN, CHINA

Learning Objectives:1. Identify process, trends, opportunities, and challenges posed by

quality improvement initiatives. 2. Discuss the strategies through leadership and collaboration that

oncology nurses can employ to get success in quality improvement of oncology care.

3. Describe tactics that help quality improvement processes to healthcare.

Ballroom BC

3.00pm – 4.20pm Concurrent Sessions

CONCURRENT SESSION C1: SYMPTOM MANAGEMENT -1CHAIR: TRACY TRUANT, CANADA

Ballroom BC

3.00pm – 3.15pmOE-31. Effect of Vaginal Mould for Preventing Vaginal Stenosis in Young Patients with Cervical Cancer

ZHEN PAN, CHINA

3.15pm – 3.30pmOE-32. Hermeneutic Phenomenological Reflections on Living with Treatment-Induced Cutaneous Toxicities

ANDREAS CHARALAMBOUS, CYPRUS

3.30pm – 3.45pmOE-33. Holistic Needs Assessment in Brain Cancer: Challenges and Opportunities

JANYNE AFSETH, UNITED KINGDOM

3.45pm – 4.00pmOE-34. Cytokine Changes Over Time and Symptom Development

BENJAMIN SCHULTZE, USA

4.00pm – 4.15pmOE-35. Teas Ameliorate Chemotherapy-Induced Bone Marrow Suppression in Lung Cancer Patients

LILI HOU, CHINA


CONCURRENT SESSION C2: HEALTH POLICYCHAIR: JUDITH JOHNSON, USA

Ballroom A

3.00pm – 3.15pmOE-36. Research Priorities for Oncology Nursing: A Delphi Study Providing the UL Perspective

EMMA REAM, UNITED KINGDOM

3.15pm – 3.30pmOE-37. Dar Al Hanan; an Award Winning Effort to Reach out to the Young Patients and Help in Compliance

FAIQA AL SINAWI, OMAN

3.30pm – 3.45pmOE-38. Integrating Oncology Content in Nursing Curricula in Malawi: A Fulbright Senior Specialist Experience

DEBORAH WALKER, USA



on CANCER NURSING

24


3.00pm – 4.20pm Concurrent Sessions 3.45pm – 4.00pm

OE-39. Breast Cancer Early Detection and Care Strategies for Policy Makers in Nigeria

AGATHA OGUNKORODE, CANADA

4.00pm – 4.15pmOE-40. An Introduction of Establishing Benevolence Supermarket in Cancer Center

QU WEN, CHINA


CONCURRENT SESSION C3: GLOBAL CARECHAIR: YAEL BEN GAL, ISRAEL

Sung

3.00pm – 3.15pmOE-41. The Discursive Construction of Ovarian Cancer in Women’s Magazines: Implications for Cancer Nursing

MERIDITH BURLES, CANADA

3.15pm – 3.30pmOE-42. Turkish Adaptation of Cancer Behavior Inventory – Brief Version: A Validity and Reliability Study

EMINE LYIGUN, TURKEY

3.30pm – 3.45pmOE-43. Mapping the Evidence for Cancer Rehabilitation

JOANNE FISHER, UNITED KINGDOM

3.45pm – 4.00pmOE-44. Innovative Delivery Model Supporting Visitor Experience within Cancer Centre in Western Australia

LESLEY MILLAR, AUSTRALIA

4.00pm – 4.15pmOE-45. Survey on the Knowledge of Osteoporosis in Breast Cancer Patients Undergoing Aromatase Inhibitors

ZIFANG JIANG, CHINA


INSTRUCTIONAL SESSION C4: TRANSFORMING CANCER SURVIVORSHIP CARE – AN AUSTRALIAN EXPERIENCECHAIR: RAYMOND CHAN, AUSTRALIA

SPEAKERS: NICOLE KINNANE, AUSTRALIA, AND AMANDA PIPER, AUSTRALIA

Learning Objectives:1. Understand the Australian experience of implementing innovative

survivorship programs and how this transfers to a global workforce2. Understand how to apply tools and resources to deliver survivorship care

Ching



INSTRUCTIONAL SESSION D1 – CHEMOTHERAPY EXTRAVASATION: EVIDENCE BASED PRACTICE FOR PREVENTION AND MANAGEMENTCHAIR: TBD

SPEAKER: SHEJILA CHILLAKUNNEL HUSSAIN RAWTHER, INDIA

Learning Objectives:1. At the end of the first session the participants will get an overview of

extravasation including incidence, risk factors, signs and symptoms, knowledge gaps and controversies regarding vesicant extravasation management

2. After completion of the second session participants will be able to discuss the treatment approaches and methods to prevent complications based on current evidence guidelines

Ballroom BC

www.isncc.org


25



INSTRUCTIONAL SESSION D2 – TEACHING ONCOLOGY NURSING THROUGH DISTANCE LEARNING: THE PHILIPPINE EXPERIENCECHAIR: STELLA BIALOUS, USA

SPEAKERS: RITA RAMOS, PHILIPPINES, MARLON SARIA, USA AND LOYDA AMOR CAJUCOM, PHILIPPINES

Learning Objectives:1. The participant will be able to describe the development of an

Oncology Nursing course for graduate students provided through distance learning

2. The participant will be able to discuss the challenges of providing an Oncology Nursing course through distance learning and the various teaching-learning techniques utilized that have been perceived by students as effective in achieving the basic knowledge and skills in oncology nursing.

Ballroom A

5.00pm – 6.00pm POSTER SESSION 1 MOVE OUT Tang & Tang Foyer

6.00pm – 6.30pm POSTER SESSION 2 MOVE INPlease have your poster displayed before 7.30am on Tuesday, 6 September.

Tang & Tang Foyer

Conference Day 2: Tuesday 6 September 2016

Pastries and fruit provided. Ballroom Foyer



7.00am – 8.00am ISNCC Communications Committee Meeting

Business CentreISNCC Member Development Committee Meeting

Ching

8.00am – 9.00amPLENARY SESSION IIInternational Psycho-Oncology Society (IPOS) International Partner Joint Session CHAIR: SUSAN BECK, USA

Is it the Most Frequent Unmet Supportive Care Needs that Predict Caregivers’ Anxiety and Depression? Results from Australia’s Partners and Caregivers Longitudinal Well-being Study.

SPEAKER: SYLVIE LAMBERT, CANADA

Unmet Supportive Care Needs in Women with Breast Cancer Across Asia

SPEAKER: RICHARD FIELDING, CHINA

Learning Objectives:1. Recognise the similarities and differences in unmet supportive care

needs in women with breast cancer from different Asian countries.2. Identify commonalities in unmet supportive care needs across national

and cultural groups of women with breast cancer from different Asian countries.

3. Infer intervention strategies to target unmet supportive care needs in women with breast cancer from different Asian countries.

Ballroom BC



on CANCER NURSING

26


9.10am – 10.30am Concurrent Sessions

CONCURRENT SESSION E1: PALLIATIVE & END OF LIFE CARE -2CHAIR: MARGARET FITCH, CANADA

Ballroom BC

9.10am – 9.25am OE-46. Chinese Oncology Nurses’ Knowledge and Perceived Competence in End-of-Life Care for Cancer Patients

RUISHUANG ZHENG, CHINA

9.25am – 9.40am OE-47. An Investigation of Recognition on End-of-Life Care among Oncology Nurses in Mainland China

BO XU, CHINA

9.40am – 9.55am OE-48. Audit of the Palliative Care Practitioners’ Adherence to WHO Pain Management Guidelines in Zambia

PATIENCE MBOZI, ZAMBIA

9.55am – 10.10am OE-49. A Thematic Analysis of Nursing Students’ End-of-Life Knowledge SUSANNA EDWARDS, CANADA

10.10am – 10.25am OE-50. Medicinal Cannabis for Cancer-Related Anorexia and Cachexia: An Anonymous Patient Survey

JANE PHILLIPS, AUSTRALIA


CONCURRENT SESSION E2: WORKFORCECHAIR: EVA GALLAGHER, USA

Ballroom A

9.10am – 9.25am OE-51. Building Capacity through Experiential LearningEMMA COHEN, AUSTRALIA

9.25am – 9.40am OE-52. A National Cancer Nursing Workforce Development Project: Assessing Reach and Impact 10 Years On

KYLIE ASH, AUSTRALIA

9.40am – 9.55am OE-53. Improving Staff Compliance with Chemotherapy Administration: A Tawam Experience

SUZANNE OAKLEY, UNITED ARAB EMIRATES

9.55am – 10.10am OE-54. Nurses’ Physical Activity Engagement: Motivators, Barriers and Work Environment Interventions

DAN LOUIE RENZ TATING, PHILIPPINES

10.10am – 10.25am OE-55. Engaging Clinical Oncology Nursing Team with a Staff Wellness Program using Small Team Approach

KA HUNG KONG, USA


MANDARIN CONCURRENT SESSION E3: QUALITY & CARECHAIR: WENDY LAM, CHINA

Sung

9.10am – 9.25am OM-1. Cultural Barriers to Family CaregivingLICHYUN YEH, TAIWAN

9.25am – 9.40am OM-2. Three Kinds of External Use in the Prevention Effect of Radiation Dermatitis

LUO XIA, CHINA

www.isncc.org


27



9.40am – 9.55am OM-3. Applying Winter Camp as Strategy of Nursing Recruitment SHIHPING PAN, TAIWAN

9.55am – 10.10am OM-4. Effects of Ionizing Irradiation on Physical Properties of a Peripherally Inserted Central Catheter

TING ZHANG, CHINA

10.10am – 10.25am OM-5. Medication Status of Cancer Patients with Oral Chemotherapy in Home

RONG ZHOU, CHINA


INSTRUCTIONAL SESSION E4: PATIENT AND PUBLIC INVOLVEMENT IN CANCER: PUTTING THE RHETORIC INTO ACTIONCHAIR: MEGAN ROGERS, AUSTRALIA

SPEAKERS: JANYNE AFSETH, UNITED KINGDOM, SUSANNE CRUICKSHANK, UNITED KINGDOM AND VIVIENNE WILSON, UNITED KINGDOM

Learning Objectives:1. Participants will be able to assess the appropriateness of different

methods and strategies for PPI in their work to enhance involvement in healthcare research and service development

2. Participants will be able to critically participate in debates about the assessment of impact of PPI and to evaluate its effectiveness.

Ching




CONCURRENT SESSION F1: SYMPTOM MANAGEMENT -2CHAIR: PATSY YATES, AUSTRALIA

Ballroom BC

10.50am – 11.05am OE-56. A Combined Content and Thematic Analysis of Advanced Lung Cancer Patients’ Exercise Experience

PI-HUA CHANG, TAIWAN

11.05am – 11.20am OE-57. A Study of Platinum-Based Chemotherapy-Induced Nausea and Vomiting, and Psychological Status

QIANQIAN MOU, CHINA

11.20am – 11.35am OE-59. Acute Oncology Chemotherapy and Radiotherapy Triage Clinic JEANETTE RUSSELL, UNITED KINGDOM

11.35am – 11.50am OE-60. Systematic Review of Non-Pharmacological Methods to Minimize Salivary Gland Damage Following RAI

ANDREAS CHARALAMBOUS, CYPRUS


CONCURRENT SESSION F2: CARE DELIVERY -2CHAIR: ANNIE YOUNG, UNITED KINGDOM

Ballroom A

10.50am – 11.05am OE-61. The Effectiveness of Spiritual Care on Reducing Depression Symptoms in Patients with Cancer

DI WEI, CHINA



on CANCER NURSING

28



11.05am – 11.20am OE-62. Implementing an Electronic Oncology Assessment Tool: Improving Communication and Patient Outcomes

SUZANNE OAKLEY, UNITED ARAB EMIRATES

11.20am – 11.35am OE-63. Impact of Switching from IV to SC Trastuzumab (TX) in the Management of HER2 Positive Breast

HELEN ROE, UNITED KINGDOM

11.35am – 11.50am OE-64. Medication Adherence of Oral Chemotherapy in Chinese Colorectal Cancer Patients

SIYU YANG, CHINA

11.50am – 12.05am OE-65. The Research of Applying WeChat to Transitional Care for the Postoperative Breast Cancer Patients

DI WEI, CHINA


MANDARIN CONCURRENT SESSION F3: SYMPTOMS & CARECHAIR: AIRONG LU, CHINA

Sung

10.50am – 11.05am OM-6. The Application of No Vomiting Standardized Ward Nursing Work Mode in Medical Oncology Department

YANG WANG, CHINA

11.05am – 11.20am OM-7. Observation on New Soft Silicone Dressing to Prevent Radioactive Skin Lesion in Breast Cancer

GUI WU, CHINA

11.20am – 11.35am OM-8. The Humidification Effect of Portable Spray Bottle on Out-Hospital Patients after Total Laryngectomy

QINGFENG WEI, CHINA

11.35am – 11.50am OM-9. The Impact of Multidisciplinary Continuous Nursing on Mental State of Patients with Breast Cancer

XINCHUN ZHANG, CHINA

11.50am – 12.05am OM-10. Death Attitudes in Family Caregivers of Cancer Patients: A Questionnaire Survey

TING ZHANG, CHINA

10.50am - 11.50am Concurrent Sessions

CONCURRENT SESSION F4: RAPID FIRE – ENGLISHCHAIR: DAVID LARKIN, AUSTRALIA

Ching

10.50am – 11.00am RF-E-13. Effects of Nurse-Led Fast Track Programme in Laparoscopic Colorectal Surgery

QIAN WU, CHINA

11.00am – 11.10am RF-E-15. Application of Health Belief Model Education in the Rehabilitation of Breast Cancer Patients

MENGQING SUN, CHINA

11.10am – 11.20am RF-E-16. Impact Evaluation of Integrated Holistic Care Model for Cancer Patients Receiving Chemotherapy

KATEKANOK KAMONMARTTAYAKUL, THAILAND

www.isncc.org


29



11.20am – 11.30am RF-E-18. Liver Cancer Patients Eat Well and Experience Little Nausea after Discharge when Treated with ERP

AANNA – MARIA HILTUNEN, FINLAND

11.30am – 11.40am RF-E-19. The Impact of Depression on Healthcare Utilization in Home Care Recipients with or without Cancer

JINJIAO WANG, USA

11.40am – 11.50am RF-E-20. Effect of Education on Recognition of Breast Prosthesis in Breast Cancer Patients with Mastectomy

HONG XIA GAO, CHINA

12.10pm – 1.20pm Lunch in Exhibit Hall Tang & Tang Foyer


1.50pm – 2.50pmPLENARY SESSION IIIMultinational Association of Supportive Care in Cancer (MASCC) International Partner Joint SessionCHAIR: ANNIE YOUNG, UNITED KINGDOM

Peripheral Neuropathies After Chemotherapy: A Challenging and Under-researched Symptom

SPEAKER: ALEX MOLASIOTIS, CHINA

Perceptions of the Role of Oncology Nurse in Delivering Survivorship Care

SPEAKER: VIOLETA LOPEZ, SINGAPORE

Ballroom BC


CONCURRENT SESSION G1: SYMPTOM MANAGEMENT -3CHAIR: LEANNE MONTEROSSO, AUSTRALIA

Ballroom BC

3.00pm – 3.15pm OE-66. The Efficacy of Empowerment based on Education Program on the Prevention of Febrile Neutropenia

WAI CHI MAK, CHINA

3.15pm – 3.30pm OE-67. Improving Cancer Symptom Management through Knowledge Translation: Implications for Nursing Practice

DENISE BRYANT-LUKOSIUS, CANADA

3.30pm – 3.45pm OE-68. Oncodermatologic Adverse Events (DAE): Driving Nursing Practice with CREAM Principles

KATHRYN CICCOLINI, USA

3.45pm – 4.00pm OE-69. Self-Identification and Management of Hand-Food Syndrome (HFS): Effect of a Teaching Program

KALAIVANI MURUGAN, INDIA

4.00pm – 4.15pm OE-70. Evaluating Nurses’ Experience of Caring for Patients with Cancer and Dementia

CAROLE FARRELL, UNITED KINGDOM



on CANCER NURSING

30



CONCURRENT SESSION G2: FAMILY & CAREGIVERCHAIR: ANDREW DIMECH, UNITED KINGDOM

Ballroom A

3.00pm – 3.15pm OE-71. Video Modelling to Provide Support for Bereaved Caregivers of an Advanced Cancer Patient

LORRAINE HOLTSLANDER, CANADA

3.15pm – 3.30pm OE-72. Caregivers’ Burden of Patients with Neuroendocrine Neoplasms and Related Factors

LIYAN ZHANG, CHINA

3.30pm – 3.45pm OE-73. Keeping Parents’ Hope Possible: What does holistic family nursing care really look like?

MERIDITH BURLES, CANADA

3.45pm – 4.00pm OE-75. The Supportive Care Needs of Parents of Pediatric Oncology Patients in Hong Kong

WINNIE PY TANG, CHINA


MANDARIN CONCURRENT SESSION G3: RAPID FIRE CHAIR: WINNIE SO, CHINA

Sung

3.00pm – 3.10pm RF-M-2. Cancer Patient’s Stress Appraisals and Depression: Implications for Providing Social Support

XIAONA QI, CHINA

3.10pm – 3.20pm RF-M-8. Effect of Intervention on Self-Image of Breast Cancer Patients after Breast-Conserving Surgery

QING WANG, CHINA

3.20pm – 3.30pm RF-M-11. The Establishment and Application of Safe Maintenance Mode for Patients with PICC in Xinjiang Province

LING CHEN, CHINA

3.30pm – 3.40pm RF-M-12. Risk Factors and Prevention Strategy of Malposition of Peripherally Inserted Central Catheter

SHAOYONG WU, CHINA

3.40pm – 3.50pm RF-M-14. Study on the Relationship Between Job Fatigue and Job Satisfaction of Cancer Nurses

YANHUA TENG, CHINA

www.isncc.org


31



INSTRUCTIONAL SESSION G4: CROSS SECTIONAL CARE DELIVERY ACROSS CANCER PATIENT DISEASE JOURNEY IN HONG KONG SETTINGCHAIR: SIN TING WONG, CHINA

SPEAKERS: LAI LOR NG, CHINA, WAI MAN LING, CHINA, YIN PING CHOY, CHINA AND ANNDA LUM, CHINA

Learning Objectives:1. Discussing different approaches to and strategies for enhancing

collaboration in cancer care, streamlining the care and service delivery during different transition periods of patient’s cancer journey

2. Overseas participants can get a better understanding on the characteristics of cancer care in the public healthcare system of Hong Kong, which may be different with their own countries.

Ching

4.20pm – 4.40pm Coffee/Tea break with Exhibits and Poster Session 2 Tang & Tang Foyer

4.40pm – 5.30pm DISTINGUISHED MERIT AWARDCHAIR: STELLA BIALOUS, USA

Reflections Across 4 Decades in Cancer Nursing – A Journey from Human to Population Perspectives

SPEAKER: SANCHIA ARANDA, PRESIDENT ELECT UICC, AUSTRALIA

Sung

5.30pm – 6:30pm POSTER SESSION 2 MOVE OUT Tang & Tang Foyer

6.30pm – 8.30pm POSTER SESSION 3 MOVE INPlease have your poster displayed before 7.30am on Wednesday, 7 September.

Tang & Tang Foyer

5.40pm – 6.30pm ISNCC GENERAL BUSINESS MEETINGISNCC members – join us to learn more about ISNCC’s activities and leadership!

Sung

6.45pm – 8.30pm MEMBER COUNCIL DINNER MEETING* Ming

8.30pm – 9.30pm PRESIDENT’S SOCIAL* Ming Terrace

Conference Day 3: Wednesday 7 September 2016

Pastries and fruit provided. Ballroom Foyer



7.00am – 8.00am ISNCC CORPORATE AND PHILANTHROPIC DEVELOPMENT COMMITTEE MEETING

Business Centre




on CANCER NURSING

32


8.00am – 9.00amPLENARY SESSION IVEuropean Oncology Nursing Society (EONS) International Partner Joint SessionCHAIR: ANDREAS CHARALAMBOUS, CYPRUS

Enhancing Recognition of the Nursing Contribution to Cancer Care: Current Challenges and Solutions in Europe

SPEAKER: MARY WELLS, UNITED KINGDOM

Learning Objectives: 1. To reflect on current challenges facing cancer nurses and cancer

nursing2. To consider the evidence on the contribution that cancer nurses make

to improving cancer care 3. To learn about the work of the European Oncology Nursing Society in

addressing current challenges and recognising cancer nursing across Europe

Ballroom BC


CONCURRENT SESSION H1: PSYCHOSOCIAL CARECHAIR: MYRNA MCLAUGHLIN-ANDERSON, PANAMA

Ballroom BC

9.10am – 9.25am OE-76. Cancer Diagnosis: Impact on Psychological Status of Indian Women with Breast Cancer

SHEJILA CHILLAKUNNEL HUSSAIN RAWTHER, INDIA

9.25am – 9.40am OE-77. Predictors of Self-Reported Satisfaction and Outcomes of Cancer Council WA Counselling Program

LESLEY MILLAR, AUSTRALIA

9.50am – 9.55am OE-78. Body Image and Sexuality Concerns of Patients with Recurrent Head and Neck Cancer

BETHANY RHOTEN, USA

9.55am – 10.10am OE-79. Psychological Distress among Elderly Patients with Cancer YONGXIA SONG, CHINA

10.10am – 10.25am OE-80. A Longitudinal Study of Body Image in Young Breast Cancer Patients During Postoperative Chemotherapy

HOU SHENGQUN, CHINA


CONCURRENT SESSION H2: INNOVATIONSCHAIR: ANDREW DIMECH, UNITED KINGDOM

Ballroom A

9.10am – 9.25am OE-81. Problem Solving for Better Health-Nursing: Application to a Cancer Hospital in China

AIRONG LU, CHINA

9.25am – 9.40am OE-82. The Contribution of Prostate Cancer Specialist Nurses: Perspectives of Clinicians

JULIE SYKES, AUSTRALIA

9.50am – 9.55am OE-83. Oral Chemotherapy: Enhancing Nursing Practice in Four Latin American Countries

TRACY TRUANT, CANADA

www.isncc.org


33



9.55am – 10.10am OE-84. Development of a Pilot Randomised Controlled Trial: Lymphoma Nurse-Led Model of Survivorship Care

LEANNE MONTEROSSO, AUSTRALIA

10.10am – 10.25am OE-85. Plastics and Breast Reconstruction Advanced Nurse Practitioner: Impact of the Role in a Cancer Centre

JON KNOX, UNITED KINGDOM


CONCURRENT SESSION H3: SURVIVORSHIP -2 CHAIR: MYRNA DOUMIT, LEBANON

Sung

9.10am – 9.25am OE-86. Activities of Daily Living Problems in Elderly Cancer Survivors ELLEN KARINE GROV, NORWAY

9.25am – 9.40am OE-87. Development of a Survivorship Care Plan and Treatment Summary for Lymphoma Survivors

LEANNE MONTEROSSO, AUSTRALIA

9.50am – 9.55am OE-88. Combining Manual Lymph Drainage with Physical Exercise Effectively Prevents Axillary Web Syndrome

ZHU XIN, CHINA

9.55am – 10.10am OE-89. Relationships among Fatigue, Depressive Symptoms, and Quality of Life in Childhood Cancer Survivors

HO CHEUNG WILLIAM LI, CHINA

10.10am – 10.25am OE-90. The First Two Years after Colorectal Cancer Treatment: UK Colorectal Wellbeing (CREW) Cohort Study

JANE WINTER, UNITED KINGDOM


INSTRUCTIONAL SESSION H4: IMPLEMENTING INTERNATIONAL SEPSIS BEST PRACTICES FOR CANCER PATIENTS: A GLOBAL PERSPECTIVECHAIR: BRENDA SHELTON, USA

SPEAKERS: ROSARIO REYES, SINGAPORE AND MAHMOUD ABDUL RAHIM HASAN, UNITED ARAB EMIRATES, BRENDA SHELTON, USA

Learning Objectives:1. Describe key elements of the recommended “Surviving Sepsis

bundled interventions”.2. Discuss the challenges that these international best practices present

in caring for cancer patients and strategies that clinicians have used to overcome barriers to their implementation.

Ching





on CANCER NURSING

34



CONCURRENT SESSION I1: SYMPTOM MANAGEMENT -4 CHAIR: KARIS CHENG, SINGAPORE

Ballroom BC

10.50am – 11.05am OE-91. Nurses’ Attitudes and Practices About Patient Activation and Self-Management Support in Cancer Care

DENISE BRYANT-LUKOSIUS, CANADA

11.05am – 11.20am OE-92. Cancer-Related Fatigue in NSCLC Patients Treated with Transcutaneous Electrical Acupoint Stimulation

YIFAN WU, CHINA

11.20am – 11.35am OE-93. Patients with Chemotherapy-Induced Peripheral Neuropathy: A Qualitative Research of Symptom Experience

YUE WANG, CHINA

11.35am – 11.50am OE-94. Chemotherapy-Induced Peripheral Neuropathy (CIPN). Incidence & Assessment Evaluation

EMMA LACEY, AUSTRALIA

11.50am – 12.05pm OE-95. Knowledge, Attitude and Practice on Chemotherapy-Induced Peripheral Neuropathy among Oncology Nurses

YUE WANG, CHINA


CONCURRENT SESSION I2: HEALTH SYSTEMSCHAIR: SUSANNE CRUICKSHANK, UNITED KINGDOM

Ballroom A

10.50am – 11.05am OE-96. Collecting Accurate Data within an Adolescent and Young Adult Cancer Service; is there a need?

DI SAWARD, AUSTRALIA

11.05am – 11.20am OE-97. ISNCC Collaborative on Cervical Cancer Screening in Latin America

CATHERINE JOHNSON, AUSTRALIA

11.20am – 11.35am OE-98. An Interpretive Description of Internet Cancer Information Use by Newly Diagnosed Individuals

KRISTEN HAASE, CANADA

11.35am – 11.50am OE-100. The Effectiveness of an Integrated Palliative Care Program for Patients with Cancer in China

XIANGYU LIU, CHINA


CONCURRENT SESSION I3: RAPID FIRE – ENGLISH CHAIR: MEGAN ROGERS, AUSTRALIA

Sung

11.00am – 11.10am RF-E-25. Ipsilateral Arm Usage for Chemotherapy in Breast Cancer? ELAINE LENNAN, UNITED KINGDOM

11.10am – 11.20am RF-E-26. The Control Study Between Follow-Up Based on the Cloud Platform with Traditional Telephone Follow-Up

YU LIU, CHINA

www.isncc.org


35



11.20am – 11.30am RF-E-28. Building Palliative Care Capacity in Alliance of ELNEC and National Palliative Care Program Panama

MYRNA MCLAUGHLIN DE ANDERSON, PANAMA

11.30am – 11.40am RF-E-29. Views and Attitudes Towards Using Venipuncture and Cannulation After Breast Surgery

ELAINE LENNAN, UNITED KINGDOM

11.40am – 11.50am RF-E-30. Lymphedema and Fibrosis in Head and Neck Cancer Patients SHEILA RIDNER, USA


CONCURRENT SESSION I4: DECISION-MAKINGCHAIR: SUZANNE SO-SHAN MAK, CHINA

Ching

10.50am – 11.05am OE-101. Women’s Perception, Evaluation, and Satisfaction from Breast Reconstruction

VARDA SWAGER, ISRAEL

11.05am – 11.20am OE-102. Recurrent Head and Neck Cancer: Patient Decision-Making BETHANY RHOTEN, USA

11.20am – 11.35am OE-103. Cancer Patients’ Needs in the End-of-Life Period: From the Perspective of Chinese Family Members

JINGYU XU, CHINA

11.35am – 11.50am OE-104. The Efficacy of Intervention on DNR Decision Making in Cancer Patients: A Systematic Review

CHEN LI TING, TAIWAN

12.20pm – 1.20pm CORPORATE LUNCH SYMPOSIUM (OPEN TO ALL REGISTERED DELEGATES)Supported by MerckPutting the Nurse at the Center of CINV Management

SPEAKERS:

Alex Molasiotis (China), Chair Professor of Nursing & Head of School, Hong Kong Polytechnic UniversityAlexandre Chan, Pharm.D., MPH, FCCP, BCPS, BCOP Deputy Head and Associate Professor, Department of Pharmacy, National University of Singapore, Associate Professor, Duke-NUS Medical School, Specialist Pharmacist (Oncology Pharmacy), National Cancer Center Singapore, Board Member, Multinational Association of Supportive Care in Cancer, Associate Editor, Journal of Oncology Pharmacy Practice

Ballroom BC




on CANCER NURSING

36


1.50pm – 2.50pmPLENARY SESSION V: NURSING LEADERSHIP IN MULTIDISCIPLINARY CANCER CARE: ROLES AND CHALLENGESAsian Oncology Nursing Society (AONS) International Partner Joint SessionCHAIR: KEUI-RU CHOU, TAIWAN

Leading Multidisciplinary Cancer and Palliative Care Research: The Role of Nurses

SPEAKER: CARMEN CHAN, CHINA

Role of Nursing Leadership in Integrating Clinical Nurse Specialists in Cancer Care

SPEAKER: MEERA ACHREKER, INDIA

Nursing Leadership to Affect Policy Change for Cancer CareSPEAKER: KYUNG HEE LIM, KOREA

Learning objectives:1. Discuss the importance of nursing leadership in multidisciplinary

cancer care2. Discuss the roles of nursing leadership in integrating clinical nurse

specialist in cancer care3. Discuss roles of nurses in leading multidisciplinary cancer and

palliative care research4. Discuss how nursing leadership effect policy change for cancer care.5. Identify challenges encountered by oncology nurses when they are

leading multidisciplinary cancer and palliative research / services and discuss how to overcome these challenges

Ballroom BC

2.00pm – 5.00pm EXHIBITS AND POSTER SESSION 3 MOVE OUTPoster Session 3 Move Out: 2.00pm-3.00pmExhibitors Move Out: 2.00pm-5.00pm

Tang & Tang Foyer

3.00pm – 4.00pmOFFICIAL CLOSING Ballroom BC

3.00pm – 3.30pm Presidential Address and Presentation of the ISNCC Past Presidents’ Award

SPEAKER: STELLA BIALOUS, USA

3.30pm – 3.40pm ISNCC Poster Awards SPEAKER: LINDA KREBS, USA

3.40pm – 3.45pm Presentation for ICCN 2017SPEAKER: LINDA KREBS, USA

3.45pm – 4.00pm Closing Celebration with Chinese Drum ShowSPEAKER: STELLA BIALOUS, USA

www.isncc.org


37

POSTER ABSTRACT LISTINGS

Poster Session 1

Program ID

Abstract Title Presenter(s) Country

P1-1 NURSING EFFECT STUDY OF HOSPICE CARE IN PATIENTS WITH ADVANCED PANCREATIC CANCER

Xia Liu China

P1-2 EVIDENCED BASED ON PATIENTS WITH TERMINAL ILLNESS COMFORT CARE PROGRAMS

Wan Chiu Taiwan

P1-3 SPIRITUALITY AMONG PARENTS OF CHILDREN WITH CANCER AT AUBMC

Myrna Doumit Lebanon

P1-5 EMOTIONAL ISSUES FOR END-OF-LIFE CANCER PATIENTS AT HOME

Ayumi Kyota Japan

P1-6 DEVELOPING CLINICAL INDICATORS FOR PALLIATIVE CARE OF PEDIATRIC CANCER PATIENTS

Carmen WH Chan China

P1-8 APPLICATION OF NEURO-LINGUISTIC PROGRAMMING IN PALLIATIVE CARE FOR CANCER PATIENTS

Xin Peng China

P1-10 STUDENT’S UNDERSTANDING OF SUPPORT FOR PERSONS CHOOSING HOME-BASED END-OF-LIFE CARE

Junko Kakeya Japan

P1-11 A NURSING EXPERIENCE ON DEATH ANXIETY OF A PATIENT SUFFERING FROM TERMINAL HEPATOMA AT FIRST VISIT

Yi-chen Wang Taiwan

P1-13 PARTNERSHIPS IN PALLIATIVE CARE: REVIEW OF A MULTI-DISCIPLINARY OUTPATIENT SERVICE.

Helen Langhorn United Kingdom

P1-14 PALLIATIVE CARE NURSING IN OMAN; A COUNTRY’S JOURNEY

Manal Al-Zadjali Oman

P1-15 STUDY ON BUILDING A COMPETENCY MODEL FOR NURSES CARING FOR THE TERMINAL CANCER PATIENTS

Miyuki Hoshina Japan

P1-16 DEVELOPMENT AND VALIDATION OF THE SELF-CARE AGENCY SCALE OF CANCER PATIENTS IN THERAPY

Kumiko Yoshida Japan

P1-17 THE EFFECT OF SALIVATION STIMULATION METHOD FOR XEROSTOMIA OF COLOPECTAL CANCER PATIENTS

Jeong Sook Park South Korea

P1-18 DEVELOPMENT OF THE COMPREHENSIVE ASSESSMENT SCALE FOR CIPN IN SURVIVORS OF CANCER

Kiyoko Kanda Japan

P1-19 SYMPTOMS AND QUALITY OF LIFE OF ESOPHAGEAL CANCER PATIENTS PRE- AND POST-SURGERY

Yumi Watanabe Japan

P1-20 AN ILL BLOKE’S BLOG: THE USE OF BLOGGING AS A COPING STRATEGY FOR BURKITT’S LYMPHOMA

Bethany Hanan United Kingdom

P1-21 EFFICACY OF OXYCOTIN IN THE TREATMENT OF SEVERE CANCER PAIN BY RECTAL ADMINISTRATION

Yanglin Zhang China

P1-22 LATE EFFECTS OF PARTICLE THERAPY EXPERIENCED BY SURVIVORS WITH HEAD AND NECK CANCER

Asuka Ebisutani Japan



on CANCER NURSING

38

Program ID


P1-23 DEVELOPING SIMULATION CASES TO EVALUATE SEVERITY OF ACUTE/CHRONIC SKIN GRAFT VERSUS HOST DISEASE

Rumi Maeda Japan

P1-24 DEVELOPMENT OF FIRST YEAR PRACTICE TOOL FOR HEAD AND NECK CANCER SURGICAL ONCOLOGY RNS

Ji Eyun Park South Korea

P1-25 THE IMPLEMENTATION AND PROMOTION FACTORS OF THE DYSPNEA CARE IN PALLIATIVE CARE UNITS ACROSS JAPAN.

Ayumi Sugimura Japan

P1-26 LOWER ERROR RATE OF SKIN SELF-CARE IN PATIENT RECEIVING RADIATION THERAPY

Ya-Hsueh Tseng Taiwan

P1-27 DEVELOPMENT OF APPLICATION FOR REGARDING TO PERIPHERAL NERVE DISORDER CAUSED BY CANCER THERAPY

Kazuko Ishida Japan

P1-28 CURRENT STATE OF ACTIVITIES AND ROLES OF CERTIFIED NURSES IN CANCER CHEMOTHERAPY NURSING IN JAPAN

Saori Miura Japan

P1-29 A PILOT PROJECT TO IMPROVE THE MANAGEMENT OF CHEMOTHERAPY-INDUCED FEBRILE NEUTROPENIA

Tak Kei Liu China

P1-30 USING A MULTICULTURAL TRANSLATION TEAM TO TRANSLATE AN ENGLISH INSTRUMENT TO MANDARIN

Jia-Wen Guo USA

P1-33 EFFECTS OF CHEMOTHERAPY-INDUCED ALOPECIA ON MALE CANCER PATIENTS

Keiko Mori Japan

P1-34 CHEMOTHERAPY- INDUCED PAIN AND NEUROPATHY IN BREAST CANCER PATIENTS

Boonyard Munaudsa

Thailand

P1-35 CASE MANAGEMENT MODEL IS APPLIED TO ANALYZE THE EFFECTIVENESS OF INTERVENTION FOR CANCER PATIENTS

Chang Chan Taiwan

P1-36 CHANGES IN MENOPAUSAL SYMPTOMS IN PREMENOPAUSAL BREAST CANCER PATIENTS UNDERGOING ENDOCRINE THERAPY

Yuko Arahori Japan

P1-37 CHANGES OF EATING BEHAVIOR, PHYSICAL SYMPTOM, AND SELF-CARE ABILITY IN POST-GASTRECTOMY PATIENTS

Kayo Toyofuku Japan

P1-38 MEDICATION ADHERENCE IN COLORECTAL CANCER PATIENTS WITH ADJUVANT CAPECITABINE CHEMOTHERAPY

Yuki Nagamatsu Japan

P1-39 ORAL HEALTH BEHAVIORS AND ORAL ISSUES THAT OCCUR IN CANCER OUTPATIENTS OF PALLIATIVE CARE DEPARTMENT

Hiromi Seto Japan

P1-40 CONCEPTUAL ANALYSIS OF A FEELING OF DYSPNEA AMONG CANCER PATIENTS

Kiyoko Kanda Japan

P1-41 THE INFLUENCE OF CHEMOTHERAPY INDUCED ALOPECIA ON THE ROLE OF MOTHERS IN BREAST CANCER PATIENTS

Kayo Inoue Japan

P1-42 EFFECTS OF LOCAL HYPERTHERMIA ON PHYSIOLOGICAL AND SUBJECTIVE RESPONSES IN CANCER PATIENTS

Rieko Izukura Japan

www.isncc.org


39

Program ID


P1-43 EFFECTIVENESS OF MOISTURIZING BARRIER CREAM DURING EXTERNAL BEAM RADIATION THERAPY

Anuttra Wunnasaweg

Thailand

P1-46 THE EFFECT OF MULTIDIMENSIONAL PATHWAY HEALTH EDUCATION MODE IN NURSING OF RADIATION ESOPHAGITIS

Yunxia Zhu China

P1-47 NURSING EXPERIENCE OF AN END STAGE BREAST CANCER PATIENT WITH CHEMOTHERAPY INDUCED LEUKOPENIA

Kai-Chun Chen Taiwan

P1-48 SPECIALIST NURSE CLINIC AND MANAGEMENT PROGRAM FOR BREAST CANCER PATIENT IN PRINCE OF WALES HOSPITAL

Yuk King Hung China

P1-49 HOW DO PATIENTS WITH HEAD AND NECK CANCER PERCEIVE MANAGEMENT OF ORAL MUCOSITIS PAIN INDUCED BY CRT?

Mariko Koike Japan

P1-51 NURSING OF SMALL BOWEL GIST COMPLICATED WITH MULTIPLE METASTASIS AND ABDOMINAL WALL PERFORATION

Kai-Chun Chen Taiwan

P1-52 TRANSLATION AND VALIDATION OF THE INDONESIA VERSION OF MEMORIAL SYMPTOM ASSESSMENT SCALE (MSAS)

Haryani Haryani Taiwan

P1-53 PHYSICIANS’ PERCEPTION OF PAIN MANAGEMENT OF MUCOSITIS ASSOCIATED WITH CRT IN HEAD AND NECK CANCER

Harue Arao Japan

P1-54 CANCER AND OPPORTUNISTIC INFECTIONS AMONG THE PEOPLE LIVING WITH AIDS ON ART IN EASTERN NEPAL

Dr. Ram Mehta Nepal

P1-55 NEUROENDOCRINE CANCERS: THE NEED TO RAISE GLOBAL AWARENESS

Megan Rogers Australia

P1-56 THE LONG-TERM SYMPTOMS AND SELF-EFFICACY OF PATIENTS WITH THORACIC ESOPHAGEAL CANCER AFTER SURGERY

Kimiko Miyata Japan

Poster Session 2

Program ID


P2-1 IMMUNOTHERAPY IN CANCER TREATMENT Haihong Cai USA

P2-2 THE EFFECTS OF SERVICE BY ONCOLOGY NURSE CASE MANAGERS ON CANCER PATIENTS’ SATISFACTION IMPROVEMENT

Mei-ling Shih Taiwan

P2-3 DESCRIBING MEN’S PERSPECTIVES ABOUT ACTIVE SURVEILLANCE

Margaret Fitch Canada

P2-4 IMPACT OF ONCOTYPE DX TESTING FOR THE MANAGEMENT OF PATIENTS WITH INTERMEDIATE RISK BREAST CANCER

Helen Roe United Kingdom



on CANCER NURSING

40

Program ID


P2-5 DECISION MAKING EXPERIENCE ON BREAST RECONSTRUCTION OF WOMEN WITH BREAST CANCER IN KOREA

Myungsun Yi South Korea

P2-6 THE DECISION-MAKING PROCESS ON GOING THE ACTIVE TREATMENT OF ADVANCED PANCREATIC CANCER PATIENTS

Kanako Naito Japan

P2-7 STATE OF NURSING SUPPORT FOR DECISION-MAKING BY CANCER PATIENTS IN JAPAN

Hisako Nakao Japan

P2-8 OMAN CANCER ASSOCIATION; THE ROLE OF AN NGO IN PROMOTING HEALTH AND PREVENTING CANCER

Manal Al-Zadjali Oman

P2-10 DEVELOPMENT OF “GUIDELINES FOR SAFE HANDLING OF CANCER CHEMOTHERAPY DRUGS” IN JAPAN.

Kazue Hirai Japan

P2-12 SURVEYS OF CURRENT SITUATION OF MENTAL HEALTH AND JOB BURNOUT OF NURSES WORKING IN ONCOLOGY UNIT

Shan Liu China

P2-14 ACCURACY OF EVALUATING ACUTE/CHRONIC SKIN GVHD USING COMMON TERMINOLOGY CRITERIA FOR ADVERSE EVENTS

Rumi Maeda Japan

P2-15 PREVENTIVE EDUCATION OF ANTICANCER AGENT EXPOSURE FOR PATIENTS AND THEIR FAMILY

Michiko Yuki Japan

P2-16 EDUCATING SURGICAL WARD NUESES ON COMMUNICATING WITH TERMINALLY ILL CANCER PATIENTS ABOUT DEATH

Keiko Ban Japan

P2-17 MACMILLAN ACUTE ONCOLOGY SERVICE (MAOS):IMPROVING UNSCHEDULED CARE IN THE MANAGEMENT OF VTE

Anila Varghese United Kingdom

P2-18 INTRODUCTION OF THE GASTRO REFERRAL PATHWAY (GRP): MAXIMISING EARLY CANCER NURSE COORDINATION

Michelle Davies Australia

P2-20 EFFECTS OF HUMANISTIC CARE ON THE SELF-CARE ABILITY OF POSTOPERATIVE PATIENTS OF BREAST CANCER

Di Wei China

P2-21 EXTENDING THE INTERVAL FLUSHING FOR PORT-A-CATHETER IN HEMATOLOGICAL CANCER PATIENTS

Mei-Bih Chen Taiwan

P2-22 THE EFFECT OF ADDING “COMFORT CARE COURSE” IN NEW NURSE’ PRE-EMPLOYMENT TRAINING PROGRAM.

Shu-Hui Liu Taiwan

P2-25 APPLICATION OF FAST TRACK SURGERY IN PERIOPERATION NURSING OF COLORECTAL PATIENTS

Hui Zhu China

P2-26 APPLICATION OF CONTINUOUS MEDICAL SERVICE BASED ON NETWORK IN PATIENTS WITH PICC DURING DISCHARGE

Ping Gong China

P2-27 THE EFFECT OF NURSE-LED PEER DISCUSSION GROUP IN COLORECTAL CANCER PATIENTS EDUCATION

Xiao Xin China

www.isncc.org


41

Program ID


P2-28 EFFECTIVENESS OF NURSE CASE MANAGEMENT COMPARED WITH USUAL CARE IN CANCER PATIENTS IN TAIWAN

Hui-Fang Tung Taiwan

P2-29 ESTABLISHMENT OF THE JEJUNOSTOMY CLINICAL CARE GUIDELINE FOR ESOPHAGEAL CANCER PATIENTS

Yu-Chu Pai Taiwan

P2-31 THE IMPORTANCE OF SUPPORTIVE CARE NEEDS AND RELATED FACTORS AMONG WOMEN WITH GYNECOLOGIC

Yue Qu China

P2-33 IS IT TIME TO IMPLEMENT 12-HOUR SHIFT FOR TAIWAN NURSES?

Li-Ting Wang Taiwan

P2-36 RELATIONSHIPS AMONG FATIGUE, CANCER WORRY AND QUALITY OF LIFE IN ORAL CANCERS PATIENTS

Ya-Lan Chang Taiwan

P2-37 SURVEY OF THE SAFE HANDLING OF HAZARDOUS DRUGS BY NURSES IN JAPAN

Keiko Iino Japan

P2-38 THE EFFECTIVENESS OF CLOSED-SYSTEM DRUG TRANSFER DEVICE FOR CHEMOTHERAPY ADMINISTRATION

Ming-Ying Hong Taiwan

P2-39 RESPONDING TO TELEPHONE PATIENT REPORTED CHANGE IN CLINICAL STATUS: POLICY AND ALGORITHM DEVELOPMENT

Catherine Barratt Australia

P2-42 NURSING CARE AND SAFETY FOR OUTPATIENT WITH CT GUIDED PERCUTANEOUS TRANSTHORACIC NEEDLE BIOPSY (PTNB)

Wu Tsumei Taiwan

P2-43 EFFECT OF AN INPATIENT NURSING RISK EARLY WARNING AND CONTROL SYSTEM IN SHANGHAI

Qian Wu China

P2-46 USING OSCE INCREASE THE COMPLETENESS OF PHYSICAL EXAMINATION OF ONCOLOGY NURSE PRACTITIONER

Chiao Hui Lin Taiwan

P2-47 EFFECTIVENESS OF 24 HOUR LIFELINE SERVICE FOR HEPATOCELLULAR CARCINOMA PATIENTS

Chen Yi Taiwan

P2-48 IDENTIFYING SERVICE GAPS IN PROSTATE CANCER PATIENTS

Junko Kakeya Japan

P2-50 IMPROVEMENT PROJECT FOR REDUCING INCIDENCE OF FALLS OF ONCOLOGY PATIENTS BY FALL-RISK RATING

Yun-Hsuan Shih Taiwan

P2-51 FALL PREVENTION PROJECT BY SMALL TEAM APPROACH TO ENHANCE PATIENT SAFETY AT CLINICAL ONCOLOGY WARD

Shuk Yee Lam China

P2-52 EMPOWERING SPANISH SPEAKING CANCER PATIENTS ON CANCER PAIN VIA AN INTERACTIVE PAIN EDUCATION PROGRAM

Gloria Juarez USA

P2-53 THE EVALUATION OF MUSIC INTERVENTION FOR CANCER PATIENTS’ ANXIETY, DEPRESSION, PAIN, AND FATIGUE

Kuei-Ru Chou Taiwan

P2-55 PREDICTORS OF VISITING EMERGENCY ROOM IN HEMATO-ONCOLOGIC PATIENTS

Jeong Sook Park South Korea



on CANCER NURSING

42

Program ID


P2-56 AUTOGENIC TRAINING MAY ENHANCE THE IMMUNE FUNCTION OF THE ORAL CAVITY

Chika Minowa Japan

P2-57 THE INFLUENCE OF THE MODE OF SBAR COMMUNICATION IN NURSE-DOCTOR COLLABORATION MODE

Weiping Li China

P2-58 EVOLVING TECHNOLOGY THAT PROMOTES PATIENT INDEPENDENCE: EXAMPLE FROM A CHEMOTHERAPY UNIT IN THE UK

Kate Edridge United Kingdom

P2-59 A CLINICAL NURSING PATHWAY IN THE STANDARD MANAGEMENT OF PATIENTS WITH RADIODERMATITIS

Hui Yang China

P2-61 WORK STRESS AMONG HAEMATO-ONCOLOGY & BONE MARROW TRANSPLANT NURSES IN NORTH INDIA

Sangeetha Samuel India

Poster Session 3

Program ID


P3-1 RESILIENCE AND COPING STRATEGIES INFLUENCING THE QUALITY OF LIFE IN PATIENTS WITH BRAIN TUMOR

Shu-Yuan Liang Taiwan

P3-2 EFFECTS OF APPRAISALS OF ILLNESS ON ANXIETY AND QUALITY OF LIFE IN COUPLES OF PROSTATE CANCER

Ching-Hui Chien Taiwan

P3-4 PRACTICE AND EXPERIENCE OF NURSES COMBINE PHARMACISTS ABOUT HEALTH EDUCATION IN PATIENTS WITH PAIN

Baoling Li China

P3-5 NURSING EXPERIENCE CARING FOR A PATIENT WITH BONE METASTASIS FROM LUNG CANCER

Shin-Na Lee Taiwan

P3-6 RELIABILITY AND VALIDITY OF A JAPANESE VERSION OF THE QUALITY OF LIFE INDEX IN CANCER PATIENTS

Michiyo Mizuno Japan

P3-7 THE PROTECTIVE FACTORS OF DEMORALIZATION IN CANCER PATIENTS IN TAIWAN

Yu Chi Li Taiwan

P3-9 SLEEP QUALITY AND ITS IMPACT ON THE PRIMARY CAREGIVER OF PATIENTS WITH GASTRIC CANCER

Nan Hao China

P3-11 PARENTAL SUPPORT: EVALUATING A THEORY-BASED HOPE INTERVENTION

Meridith Burles and Lorraine Holtslander

Canada

P3-14 DEVELOPMENT OF LEARNING MATERIALS ON CANCER FAMILY CARE FOR JAPANESE GENERAL WARD NURSES

Satoko Chou Japan

P3-16 SLEEP DISTURBANCE IN HOSPITALIZED RECIPIENTS OF HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT)

Rutuja Dandekar India

P3-17 VALIDATION OF THE CHINESE VERSION GLOVER NILSSON SMOKING BEHAVIOR QUESTIONNAIRE IN TAIWANESE SMOKERS

Hsi-Ling Peng Taiwan

P3-18 IMPLEMENTATION A CENTRAL LINE CARE BUNDLE IN HOSPITALIZED ONCOLOGY PATIENT

Sheung Ling Chan China

www.isncc.org


43

Program ID


P3-19 EVIDENCE FOR THE ASSOCIATION OF GLYCEMIC INDEX AND CANCER RISK

Carmen WH Chan China

P3-20 OVERVIEW OF JSCN/JSMO/JASPO JOINT GUIDELINES FOR SAFE HANDLING OF CANCER CHEMOTHERAPY DRUGS IN JAPAN

Kiyoko Kanda Japan

P3-21 SMOKING CESSATION COUNSELING BEHAVIORS IN TOBACCO CONTROL SEED INSTRUCTORS IN TAIWAN

Hsiu-Wen Tsai Taiwan

P3-23 DELAY OF HELP SEEKING BEHAVIOR IN JAPANESE BREAST CANCER PATIENTS.

Mariko Oshiro Japan

P3-24 A STUDY OF DEMOGRAPHIC FACTOR ON RISK OF BREAST CANCER

Tso-Ying Lee Taiwan

P3-26 FACTORS THAT INFLUENCE PSYCHOLOGICAL DISTRESS AMONG CANCER SURVIVORS

Isako Ueta Japan

P3-27 TEXT MINING ANALYSIS OF POST-DISCHARGE OF ELDERLY PATIENTS RECEIVING ORAL RADIOACTIVE IODINE THERAPY

Junko Yoshimura Japan

P3-28 A STUDY ON A NURSING INTERVENTION TO INCREASE FULFILLMENT IN THE FIRST RECURRENCE BREAST CANCER

Naomi Ota Japan

P3-29 MOOD STATE PARAMETERS IN PATIENTS BEFORE ROBOT-ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY (RALP)

Yoko Miyoshi Japan

P3-30 KING’S HEALTH QUESTIONNAIRE (KHQ) AFTER ROBOT-ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY (RALP)

Yoko Miyoshi Japan

P3-31 EXPERIENCE ON PATIENTS WITH CANCER OF UNKNOWN PRIMARY: FROM ONSET OF SYMPTOMS TO INITIAL TREATMENT

Kyoko Ishida Japan

P3-32 CHANGES OF UNMET SUPPORTIVE CARE NEEDS IN KOREAN WOMEN WITH NEWLY DIAGNOSED BREAST CANCER

Jin-Hee Park South Korea

P3-33 HOPE AND COPING BEHAVIORS IN LUNG CANCER PATIENTS WITH POST-OPERATIVE ADJUVANT THERAPY

Takae Bando Japan

P3-34 PATIENT EDUCATION IN ENHANCED RECOVERY PROTOCOLS IN CANCER SURGERY – A LITERATURE REVIEW

Anna-Maria Hiltunen

Finland

P3-36 PSYCHOLOGICAL SUPPORT AND THE HOPE OF THE LUNG CANCER PATIENTS RECEIVING CHEMOTHERAPY

Hiroko Ota Japan

P3-39 PSYCHOLOGICAL EXEPERIENCES AFTER LRP WHO HAVE SUFFERED FROM UI

Haiqin Hu China

P3-40 CAUSES OF STIGMA IN CANCER PATIENTS: A LITERATURE REVIEW

Tomoko Otsuka Japan

P3-41 THE SPIRITUAL JOURNEY OF FEMALE BREAST CANCER PATIENTS UNDER ADJUVANT THERAPY IN TAIWAN

Liao Yu Chen Taiwan



on CANCER NURSING

44

Program ID


P3-42 THE APPLICATION EFFECT OF PSYCHOLOGICAL NURSING IN THE NURSING OF TUMOR PATIENTS.

Jing Yao China

P3-43 CLINICAL APPLICATION OF THE DISTRESS THERMOMETER TO PATIENTS WITH LUNG CANCER

Boyong Shen China

P3-45 SURVIVORSHIP : A COLLABORATIVE APPROACH Sian Middleton United Kingdom

P3-48 SUBJECTIVE EVALUATION OF A PEER SUPPORT PROGRAM BY WOMAN WITH BREAST CANCER.

Miho Ono Japan

P3-49 SURVIVORSHIP EDUCATION FOR LATINA BREAST CANCER SURVIVORS: EMPOWERING SURVIVORS THROUGH EDUCATION

Gloria Juarez USA

P3-51 THE EXPERIENCE OF AN ELDERLY CANCER SURVIVOR COUPLE UNDERGOING OUTPATIENT CHEMOTHERAPY

Megumi Nagoshi Japan

P3-52 FACTORS FOR ENHANCING CANCER SURVIVORS’ INFORMATION LITERACY

Satsuki Kubo Japan

P3-53 THE EFFECTS OF A SKIN CAMOUFLAGE PROGRAM ON FEMALES WITH HEAD AND NECK CANCER

Shu-Ching Chen Taiwan

P3-54 SUPPORT, BARRIER, PLANNING ON HEALTHY HABIT AND QUALITY OF LIFE IN COLORECTAL CANCER PATIENTS

Myung Lee South Korea

P3-55 PROCESS OF BREAST CANCER RECEIVING CHEMOTHERAPY ACCEPT THE CHANGE OF OWN APPEARANCE

Miho Naito Japan

P3-56 EXPERIENCE OF DEATHBED CANCER PATIENT WITH THE CONCEPT CANCER SURVIVOR

Tu Wen Yi Taiwan

P3-60 THE EFFECTS OF SEMI-RECUMBENT IN THE EARLY PERIOD AFTER PULMONARY LOBECTOMY

Fen Gu China

P3-62 SELF-REPORTED DEPRESSION AMONG PATIENTS WITH NON-SMALL CELL LUNG CANCER

Yumei Li China

P3-63 A STUDY OF NUTRITIONAL STATUS DURING RADIOTHERAPY IN DIFFERENT AGE PATIENTS WITH ESOPHAGEAL CANCER

Yingjun Ye China

www.isncc.org


45

ABOUT OUR SUPPORTERS

Asian Oncology Nursing Society (AONS)

Founded in 2013, the Asian Oncology Nursing Society (AONS) is a professional organization which supports cancer nurses to be well-prepared in providing high quality and science based care for cancer patients in Asia. AONS is committed to strengthening collab-orations among members, promoting the latest evi-dence-based practice for improving cancer care, and developing nursing leadership in cancer care in Asia.Learn more at http://aons.asia/mastart/mastart.php

BARD

BARD is a leading multinational developer, manu-facturer, and marketer of innovative, life-enhancing medical technologies in the product fields of Vascular, Urology, Oncology, Surgical Specialty. BARD markets its products and services worldwide to hospitals, in-dividual health care professionals and extended care facilities.BARD’s core values of Quality, Integrity, Service, and Innovation represent our reality and our aspirations. These four values prepare us for the challenges ahead and guide our everyday activities and align us to our mission. They are central to how we behave and want to be viewed by our fellow co-workers, customers, shareholders and communities.

Dale Medical Products, Inc.

Dale Medical Products, Inc. develops and manu-factures innovative post-surgical care products for the acute, sub-acute and long-term care markets,

designed to save nursing time and reduce skin ir-ritation, while leading to comfortable, trouble-free recovery.

End-of-Life Nursing Education Consortium (ELNEC)

The End-of-Life Nursing Education Consortium (ELNEC) project, which started in 2000, is a national education and international initiative to improve palliative care. The project provides undergradu-ate and graduate nursing faculty, CE providers, staff development educators, specialty nurses in pediat-rics, oncology, critical care and geriatrics, advanced practice registered nurses and other nurses with pal-liative care education, so they can teach this essential information to nursing students and practicing nurses. To date, over 21,000 nurses and other healthcare pro-fessionals, representing all 50 US states, plus 88 inter-national countries have received ELNEC training. The ELNEC project is administered by the American Asso-ciation of Colleges of Nursing (AACN), Washington, DC and the City of Hope, Los Angeles, CA.

European Oncology Nursing Society (EONS)

The European Oncology Nursing Society is a not for profit, voluntary organisation dedicated to the support and development of European cancer nurses. EONS’s vision is to ensure that people affected by cancer across Europe will benefit from the care of well-educated, informed and competent cancer nurses, who will play a central role in providing support, promoting health and improving clinical outcomes.Website: http://www.cancernurse.eu/

http://aons.asia/mastart/mastart.php

http://www.cancernurse.eu/



on CANCER NURSING

46

ICU Medical

ICU Medical helps you maximize clinician and patient safety with easy-to-use, needlefree closed system transfer devices (CSTDs) for the safe administra-tion of hazardous drugs. These CSTDs incorporate passive safety design features into every component, including bonded and locking mechanisms that help minimize hazardous drug exposure and ensure com-pliance with recommended safe handling guidelines.

International Psycho-Oncology Society (IPOS)

The International Psycho-Oncology Society (IPOS) fosters the science and practice of psychosocial oncology to improve the care people affected by cancer worldwide. The Society seeks to provide leadership and devel-opment of standards for education and research on the psychological, social and spiritual factors that affect the quality of life of cancer patients and their loved ones, and that influence tumor progression and survival. The aims of IPOS have been to foster training, encourage psychosocial principles and a humanistic approach in cancer care, and to stimulate research and develop training so psychosocial care may be integrated with all clinical oncological specialties for optimal patient care.IPOS is charitable organization with members from more than 60 different countries. www.ipos-society.org

MERCK & Co., Inc.

For 125 years, MSD has been a global health care leader working to help the world be well. MSD is a trade name of Merck & Co., Inc., Kenilworth, N.J.,

USA. Through our prescription medicines, vaccines, biologic therapies, and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to healthcare through far-reaching policies, programs and partnerships. For more information, visit www.msd.com or www.msd.XX (for country-spe-cific website).

NCI Center for Global Health

The U.S. National Cancer Institute (NCI) Center for Global Health (CGH) is the principal team responsible for coordinating and prioritizing NCI’s global activities to advance global cancer research, build expertise, and leverage resources across nations to address the challenges of cancer and reduce cancer deaths worldwide. CGH’s specific objectives are to:• Create sustainable international partnerships• Support programs that address global gaps in

research and scientific training• Disseminate information and best practices that

drive improvements in cancer research and cancer control

Oncology Nursing Society (ONS)

ONS is a professional association of more than 39,000 members committed to promoting excellence in oncology nursing and the transformation of cancer care. Since 1975, ONS has provided a profession-al community for oncology nurses, developed ev-idence-based education programs and treatment information, and advocated for patient care, all in an effort to improve quality of life and outcomes for patients with cancer and their families. Learn more at www.ons.org

http://www.ipos-society.org

http://www.msd.com/

http://www.ons.org/

www.isncc.org


47

Pfizer Oncology

Pfizer Oncology is committed to the research and discovery of breakthrough treatment options, including small molecules, biologics and immuno-therapies, to improve the outlook for cancer patients worldwide. For more information please visit www.pfizer.com.

Roche

Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest biotech company, with truly dif-ferentiated medicines in oncology, immunology, in-fectious diseases, ophthalmology and neuroscience. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics. Roche’s person-alised healthcare strategy aims at providing medicines and diagnostics that enable tangible improvements in the health, quality of life and survival of patients. Founded in 1896, Roche has been making important contributions to global health for more than a century. Twenty-eight medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines.

Royal Marsden Hospital

The Royal Marsden Hospital was the first hospital in the world dedicated to cancer treatment and research into the causes of cancer. Today the hospital with its academic partner, The Institute of Cancer Research, forms the largest comprehensive cancer centre in Europe with over 40,000 patients from the UK and abroad seen each year.

Teva Pharmaceuticals LTD.

Tevadaptor® medical device by Teva Pharmaceuticals LTD.www.tevadaptor.comTevadaptor® is a closed system for safe compounding and administration of hazardous drugs. Tevadaptor® minimizes the risk of exposure to hazardous drug sub-stances and the risk of needle-stick injuries, protecting the safety of pharmacists, nurses and patients alike.Its patented TOXI-GUARD® system, located in the vial adaptor, allows pressure equalization during use, prevents the escape of hazardous drug vapors into the environment during drug reconstitution and ad-ministration and prevents airborne contaminants and particles from entering the drug vial. Tevadaptor® is a brand of Teva Pharmaceuticals LTD. a leading global pharmaceutical company, committed to providing patients with access to high-quality health-care. Established in 1901, Teva Pharmaceutical Indus-tries Ltd. is ranked among the 10 top pharmaceuti-cal companies in the world. Headquartered in Israel, Teva is active in 60 countries, with 43,000 dedicated employees worldwide.Tevadaptor® keeps you safe in click.

http://www.pfizer.com

http://www.pfizer.com

http://www.tevadaptor.com



on CANCER NURSING

48

www.isncc.org


49



on CANCER NURSING

50

Notes

ISNCC MembershipMembership in ISNCC is available to cancer nursing associations, institutions, and individual cancer nursing professionals worldwide. As a member of ISNCC, you are a part of an international network of professionals in the field of cancer nursing. ISNCC members are encouraged to actively participate in the leadership of the Society by joining ISNCC committees that are working to advance oncology education, research, and patient care.

Visit www.isncc.org to join ISNCC! ISNCC memberships expire on December 31 of every year.

INDIVIDUAL MEMBERSHIP

Individual nurses or other professionals involved or interested in cancer nursing are eligible to become Individual Members.

As an Individual Member of ISNCC, you are entitled to benefits including:

• Exclusive access to ISNCC Insight, a unique platform for nurses to access online educational materials relevant to cancer nursing practice.

• Electronic subscription to Cancer Nursing, a bimonthly publication that address the whole spectrum of problems arising in the care and support of cancer patients.

• Access to the International Cancer Nursing News (ICNN), opportunity to submit blog posts or articles relevant to oncology nursing for consideration by the ISNCC Communications Committee, and receipt of notifications when new posts are made.

• Access to the ISNCC Community on Sosido and receipt of weekly digests summarizing all activity in the ISNCC community.

• Opportunity to join ISNCC Committees.

• Access to ISNCC discussion forum for online dialogue on pertinent international nursing issues.

• Discounted subscription rates for inPractice Oncology Nursing, a digital point-of-care reference and educational resource designed specifically for nurses who care for patients with cancer.

• Reduced rates on the International Conference on Cancer Nursing (ICCN) registration fees.

• Participation in the business meeting of the Society, held during ICCN.

• Networking opportunities via participating in society activities.

• Access to career postings in the cancer nursing field.

• Access to an extensive network of institutions, centers and individuals involved in cancer

• Opportunity to collaborate with international nurses through the ISNCC Twinning Program.

ASSOCIATION MEMBERSHIP

Oncology and related institutions, charities and organizations are eligible to become Association Members.

In addition to the benefits for Individual Members, Association Members also receive the following supplementary benefits:

• Option to host an ISNCC webinar and present research conducted at the associate institution.

• Marketing of program information via ISNCC communication channels.

• Recognition of membership on ISNCC website.

FULL MEMBERSHIP

National oncology nursing societies are eligible to become Full Members.

In addition to the benefits for Individual Members, Full Members also receive the following supplementary benefits:

• Participate in the ISNCC Member Council Meetings, held at the International Conference on Cancer Nursing (ICCN).

• Nominate individuals to receive awards or honors conferred by the Society.

• Nominate and vote for eligible individuals for the Board of Directors.

• Recognition of membership on ISNCC website.

CORPORATE MEMBERSHIP

ISNCC invites corporations to help stimulate and support an active and cohesive worldwide oncology nursing community by joining as a Corporate Member. ISNCC has a consistent and successful record of international activities that impact communities by advancing the knowledge and skills of cancer nurses, achieved through partnerships with corporations and cancer organizations. Please contact ISNCC Head Office at [email protected] if you are interested.

http://www.isncc.org

mailto:[email protected]

The premier international educational opportunity for nurses

The ICCN 2017 will offer the unique opportunity to meet with international cancer nursing leaders from all over the world, in one place at one time.

Submit an Oral or Poster Abstract Register to Attend Participate in a Committee Recommend a Plenary Speaker

Nominate for Awards Reserve your Exhibit Space Book your Educational Symposium or Tutorial

July 9-12, 2017 • Anaheim, California, USA• Sheraton Park Hotel at the Anaheim Resort

visit www.isncc.org for more details


on CANCER NURSING

INTERNATIONAL CONFERENCE ON CANCER NURSING...Nursing and Hong Kong Oncology Nursing Group, it is a...

Documents

Transcript of INTERNATIONAL CONFERENCE ON CANCER NURSING...Nursing and Hong Kong Oncology Nursing Group, it is a...